Page last updated: 2024-08-23

bromocriptine and Adenoma, Prolactin-Secreting, Pituitary

bromocriptine has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 446 studies

Research

Studies (446)

Timeframe	Studies, this research(%)	All Research%
pre-1990	30 (6.73)	18.7374
1990's	202 (45.29)	18.2507
2000's	104 (23.32)	29.6817
2010's	89 (19.96)	24.3611
2020's	21 (4.71)	2.80

Authors

Authors	Studies
Cai, X; Ma, C; Tang, C; Yang, J; Yuan, F; Zhu, J	1
Dai, C; Guan, S; Kang, J; Li, Y; Liu, H; Sun, B; Wang, W; Zhang, J	1
Chen, S; Dong, J; Gu, J; Jiang, X; Li, D; Wen, X; Zou, Y	1
Chen, Y; Wang, A; Wang, S; Wang, X; Wu, J; Zhang, Y; Zhu, K	1
Cai, X; Cong, Z; Ma, C; Tang, C; Yang, J; Yuan, F; Zhu, J	1
Auriemma, RS; Colao, A; Negri, M; Patalano, R; Pirchio, R; Pivonello, C; Pivonello, R	1
Canturk, S; Dogansen, S; Hacisahinogullari, H; Yarman, S	1
Inder, WJ; Jang, C	1
Mamelak, A	1
Cescato, VAS; Cunha-Neto, MBC; Glezer, A; Musolino, NRC; Pinheiro, FMM; Silva, GO; Stumpf, MAM	1
Miller, KK; Tritos, NA	1
Attanasio, R; Basile, M; Bozzao, A; Cappabianca, P; Caputo, M; Cozzi, R; Cruciani, F; De Menis, E; Doglietto, F; Esposito, F; Ferrante, E; Ferraù, F; Grimaldi, F; Iatì, G; Lania, AG; Laureti, S; Lello, S; Locatelli, D; Maffei, P; Mazzatenta, D; Minniti, G; Mitrova, Z; Paoletta, A; Papini, E; Peri, A; Persichetti, A; Poggi, M; Rudà, R; Ruini, C; Samperi, I; Saulle, R; Scoppola, A; Settanni, F; Silvani, A; Simona Auriemma, R; Tortora, F; Vecchi, S; Veronese, N	1
Li, D; Luo, P; Tan, H; Wang, Y; Yu, Y	1
Ajduk, J; Košec, A; Kruljac, I	1
Farrant, MT; Gunn, AJ; Milsom, SR; O'Sullivan, SM; Ogilvie, CM	1
Bronstein, MD; Glezer, A	1
He, X; Kong, C; Yang, Y; Ye, Y	1
Alemayehu, Y; Ayele, B; Mengesha, A; Wotiye, A	1
Araki, E; Hanatani, S; Igata, M; Ishii, N; Kawashima, J; Motoshima, H; Sakaguchi, M; Yagi, Y; Yoshinaga, K	1
Deng, Q; Li, Z; Liang, J; Liu, Z; Shao, Z; Song, C; Wang, X; Xiao, Z; Yang, X; Zhang, K	1
Li, Z; Liu, Z; Shao, Z; Song, C; Wang, X; Xiao, Z; Yang, X; Zhang, K	1
Chen, Y; Fang, Q; Gao, H; Gui, S; Guo, J; Li, C; Liu, C; Wang, J; Wang, Z; Xie, W; Zhang, Y; Zhao, P; Zhu, H	1
Biermasz, NR; Chanson, P; Jorgensen, JOL; Kuhn, E; Weinreich, AA	1
Carvalho, D; Souteiro, P; Teixeira, M	1
Araujo, B; Belo, S; Carvalho, D	1
Ji, MJ; Kim, JH; Kim, SY; Kim, YH; Lee, JH; Paek, SH; Shin, CS	1
Filipowicz, D; Kuśmierek, A; Mohol, J; Ruchała, M; Stajgis, M; Szczepanek-Parulska, E	1
Bilbao, I; Egaña, N; García, C; Olaizola, I	1
Jiang, CX; Qu, HQ; Tian, WJ; Wang, BP; Zhang, J; Zhu, M	1
Bao, X; Deng, K; Feng, M; Gao, J; Liu, X; Liu, Y; Wang, R; Yao, Y	1
Huang, HY; Lin, SJ; Wu, ZB; Zhao, WG	1
Lian, W; Liu, N; Wang, RZ; Xing, B; Yao, Y	1
Arlt, W; Ayuk, J; Fountas, A; Gittoes, N; Karavitaki, N; Santharam, S; Tampourlou, M; Toogood, A	1
Hu, Y; Jiang, S; Lv, L; Ma, W; Wang, X; Yang, Y; Yin, S; Zhang, S; Zhou, P	1
Almeida, R; Araújo, C; Marques, O; Santos, MJ	1
Huang, HY; Hui, GZ; Tang, H; Wu, ZB; Zhai, W	1
Bao, X; Deng, K; Feng, M; Gao, J; Han, G; Lian, W; Liu, X; Liu, Y; Lv, X; Wang, R; Xing, B; Yao, Y	1
Du, Q; Feng, Y; Jian, M; Mao, Z; Wang, H; Wang, X; Xiao, Z; Zhu, D; Zhu, Y	1
Maiter, D	1
Ding, X; Hu, JT; Li, S; Tang, HB; Yang, H; Zang, ZL; Zhang, SL	1
Du, Q; Hu, B; Jiang, X; Mao, Z; Wang, H; Wang, X; Wang, Z; Xiao, Z; Zhu, D; Zhu, Y	1
Krytskyy, T; Kulchinska, V; Naumova, L; Pasyechko, N	1
Cong, Z; Luo, X; Ma, C; Sun, R; Tang, C; Wen, G; Yang, J; Zhong, C; Zhu, J	1
Akinduro, OO; Bernet, V; Chaichana, KL; De Biase, G; Donaldson, A; Izzo, A; Lu, VM; Meyer, FB; Olomu, O; Quinones-Hinojosa, A; Van Gompel, JJ; Vilanilam, G	1
Ashida, K; Kawano, S; Nakamura, Y; Nakayama, H; Nomura, M; Ohki, T; Oshige, T; Sasaki, Y; Tajiri, Y; Tokubuchi, I; Tsuruta, M; Yamada, K	1
Bai, J; Gui, S; Zhang, Y	1
Alic, E; Dervisefendic, M; Hajder, E; Hajder, M; Samardzic, R	1
Cheng, SW; Jiang, S; Xue, XC; Yin, SL; Zhong, CH; Zhou, PZ	1
Cuevas, JL; Fernández, V; González, O; Rojas, D; Torche, E; Wohllk, N	1
Bai, J; Cao, L; Gao, H; Hong, L; Lan, X; Li, C; Lu, R; Wang, F; Wu, Y; Zhang, Y	1
Carvalheiro, M; Gomes, L; Paiva, S; Ruas, L; Saraiva, J	1
Shi, TY; Yang, YJ; Zhang, FC; Zhang, LN	1
Barkan, A; Benbassat, C; Bronstein, MD; Shapiro, J; Shimon, I; Tsvetov, G	1
Figueroa-Núñez, C; González, E; Gutierrez, M; Hernán Martínez, J; Mangual-García, M; Mansilla-Letelier, P; Miranda, Mde L; Palermo-Garofalo, C; Sánchez, A; Santiago, M; Torres, O; Trinidad, R	1
Bonadei, I; Curnis, A; D'Aloia, A; Metra, M; Piovanelli, B; Rovetta, R; Vizzardi, E	1
Ge, J; Guo, L; Qiu, Y; Zhang, N	1
Krysiak, R; Samborek, M; Stojko, R	1
Cai, L; Chen, YX; Li, WQ; Lin, SJ; Lu, JL; Shang, HB; Su, ZP; Wang, CD; Wu, ZB; Yang, WL; Zhao, WG	1
Bretón Lesmes, I; Cózar León, MV; García de Quirós Muñoz, JM; Serrano Aguayo, P	1
Bai, J; Lan, X; Li, C; Li, Z; Liu, Q; Wu, Y; Yu, G; Zhang, Y; Zong, X	1
Cámara Gómez, R; Del Olmo García, M; Merino Torres, JF; Querol Ripoll, R; Simal Julián, JA	1
Abliz, Z; He, J; Liu, Y; Wang, R; Yue, X; Zang, Q; Zhang, R	1
Lian, W; Liu, N; Wang, R; Xing, B; Yao, Y	1
Chong, KK; Li, CL; Lok, JY; Yip, NK; Young, AL	1
Couldwell, WT; Eloy, JA; Liu, JK; Wong, A	1
Alvarez Berastegui, GR; Anand, VK; Raza, SM; Schwartz, TH	1
Cheon, YH; Hahm, JR; Kim, HO; Lee, SI; Lee, WS; Oh, YJ; Suh, YS; Yoo, WH	1
Couldwell, WT; Eloy, JA; Hajart, AF; Jethwa, PR; Liu, JK; Patel, TD	1
Akhtar, S; Bakhach, M; Gonzalez-Martinez, J; Haider, A; Patel, L; Raissouni, N; Rogers, D; Schweiger, M; Tsilianidis, L	1
Cai, L; Guo, YH; Jin, K; Leng, ZG; Lin, SJ; Lu, JL; Su, ZP; Wei, LF; Wu, ZB; Wu, ZR; Zhuge, QC	1
Becu-Villalobos, D; Brie, B; Garcia Tornadu, I; Lopez Vicchi, F; Luque, GM; Nogueira, JP	1
Cai, Q; Chen, Q; Deng, G; Ji, B; Kong, DK; Li, M; Liu, B; Peng, Z; Tian, D; Wang, H; Wang, J; Wang, L; Wu, L; Xu, Z; Zhang, A; Zhang, S	1
Guo, R; Lv, J; Pan, M; Pan, Y; Zhang, Y	1
Dogansen, SC; Selcukbiricik, OS; Tanrikulu, S; Yarman, S	1
Alfieri, A; Ballarino, MC; Boero, L; Chervin, A; Danilowicz, K; Diez, S; Fainstein Day, P; García-Basavilbaso, N; Glerean, M; Guitelman, M; Katz, D; Loto, MG; Mallea-Gil, MS; Manavela, M; Martinez, M; Miragaya, K; Moncet, D; Rogozinski, AS; Servidio, M; Stalldecker, G; Vitale, M	1
Bronstein, MD; Espinosa, E; Glezer, A; Greenman, Y; Mendoza, V; Mercado, M; Popovic, V; Shimon, I; Sosa, E; Tirosh, A	1
Ding, X; Hu, G; Huang, J; Jiang, L; Sun, W; Zhang, C; Zhang, F	1
Chapman, IM; De Sousa, SM; Falhammar, H; Torpy, DJ	1
Atkinson, JL; Donegan, D; Erickson, B; Erickson, D; Jentoft, M; Meyer, F; Natt, N; Nippoldt, TB	1
Andereggen, L; Andres, RH; Beck, J; Christ, E; El-Koussy, M; Frey, J; Seiler, RW	1
Braga, J; Galvão, A; Gonçalves, D; Inocêncio, G; Moreira, M; Silva, C	1
Dhanjal, MK; Knight, M; Lambert, K; McCance, DR; Rees, K; Seed, PT; Williamson, C	1
Beckers, A; Bonneville, JF; Brue, T; Castinetti, F; Cuny, T; Dufour, H; Eroukhmanoff, J; Potorac, I; Tejedor, I; Touraine, P; Weryha, G	1
Duan, L; Gu, F; Huang, M; Yan, H; Zhang, Y	1
Gurwell, JA	1
Blevins, LS; Chang, EF; Kunwar, S; Sughrue, ME; Tyrell, JB; Wilson, CB	1
Lin, SQ; Ma, WB; Yu, Q; Zhang, YH; Zhen, JR	1
Acharya, SV; Bandgar, TR; Gopal, RA; Joshi, SR; Menon, PS; Shah, NS	1
Bolaman, Z; Coskun, A; Guney, E; Kadikoylu, G; Kucuk, M; Yavasoglu, I	1
De Paul, AL; Gutiérrez, S; Mukdsi, JH; Palmeri, CM; Petiti, JP; Sosa, Ldel V; Torres, AI	1
Bahuleyan, B; Easwer, HV; Krishna, K; Menon, G; Nair, S; Rao, BR	1
Mezosi, E; Nemes, O	1
Radojicic, A; Sternic, N; Sundic, A; Vujovic, S; Zidverc-Trajkovic, J	1
Chen, Y; Lin, C; Su, ZP; Wang, CD; Wu, JS; Wu, ZB; Zeng, YJ; Zheng, WM; Zhuge, QC	1
Albuquerque, JL; Azevedo, MF; Boguszewski, CL; Bronstein, MD; Casulari, LA; de Oliveira, AR; Dos Santos Faria, M; Gadelha, MR; Montenegro, RM; Musolino, NR; Naves, LA; Pinho Barbosa, FR; Ramos, AJ; Serfaty, FM; Vilar, L	1
Anoop, TM; Jabbar, PK; Pappachan, JM	1
Kostic, G; Markovic, I; Miljkovic, P; Radovanovic, Z; Saranac, L; Zivanovic, S	1
Amano, K; Hori, T; Izumi, S; Kawamata, T; Makino, R; Miki, N; Okada, Y; Ono, M; Seki, T; Takano, K	1
Klibanski, A	1
Bostanci, EB; Ibis, M; Karaman, K; Kurt, M; Temucin, T	1
Lee, MR	1
Barbosa, FR; Domingues, RC; dos Santos Silva, CM; Fontes, R; Gadelha, MR; Lima, GA; Warszawski, L	1
Bohmerova, K; Gavornik, P	1
Burger, P; Menucci, M; Quiñones-Hinojosa, A; Salvatori, R	1
Hong, JW; Kim, SH; Lee, EJ; Lee, SK; Yang, MS	1
Berinder, K; Hall, K; Höybye, C; Hulting, AL; Nyström, T	1
Adamidou, F; Anagnostis, P; Efstathiadou, Z; Karathanassi, E; Kita, M; Polyzos, SA	1
Azevedo, M; Boguszewski, CL; de Souza, AM; dos Santos, CM; Marini, LC; Sakamoto, KS	1
Sorisky, A; Tailor, C; Teo, I	1
Molitch, ME	6
Abad, A; Aller, J; Batista, E; Doltra, A; García-Pavía, P; Halperin, I; Lucas, T; Mirelis, JG; Mora, M; Puig-Domingo, M; Santos, AE; Sitges, M; Varela, C	1
Chen, Y; Lu, L; Sanai, N; Su, Z; Wang, C; Wu, J; Wu, ZB; Xue, X; Zheng, W; Zhuge, Q	1
Elenkova, A; Kalinov, K; Shabani, R; Zacharieva, S	1
Kedzia, A; Krysiak, R; Okopień, B	1
Bilge, A; Kurtulmus, N; Yarman, S	1
Deukmedjian, AR; Hann, S; Morrison, AD; Shah, V; Vale, FL	1
Alkabbani, A; Doshi, K; Hamrahian, A; Hatipoglu, B; Kennedy, L; Makin, V; Mon, SY; Olansky, L; Thorton, JN; Weil, R	1
Abaci, A; Altincik, A; Bober, E; Buyukgebiz, A; Can, S; Catli, G; Demir, K	1
Lou, XH; Wu, ZB; Zhang, YZ	1
Bian, X; Chen, W; Gai, M; Zhang, Y	1
Liu, C; Tyrrell, JB	1
Bronstein, MD; Musolino, NR; Passos, VQ; Souza, JJ	1
Arginteanu, MS; King, WA; Post, KD; Shrivastava, RK	1
Freed, DJ; Gillam, MP; Middler, S; Molitch, ME	1
Ishiguro, T; Iwai, Y; Komiyama, M; Matsuzaka, Y; Morikawa, T; Yamanaka, K; Yasui, T	1
Ben Slama, C; Bouguerra, R; Chamakhi, S; Essaïs, O; Hadjri, S; Hamzaoui, J; Marrakchi, Z; Zidi, B	1
Cavallero, D; Fazzuoli, L; Giusti, M; Valenti, S	1
Goadsby, PJ; Levy, MJ; Matharu, MS	1
Aizawa, T; Hashizume, K; Katai, M; Oiwa, A; Sakuma, T; Sakurai, A; Sato, Y; Yamashita, K	1
Bodack, MI	1
Gondim, J; Pinheiro, I; Ramos Júnior, F; Schops, M; Tella Júnior, OI	1
Facchetti, M; Memo, M; Missale, C; Uberti, D	1
Ball, SG; Hall, K; James, RA; Kendall-Taylor, P; Pearce, SH; Quinton, R; Sibal, L; Ugwu, P	1
Ho, WL; Shen, CC; Yang, MY	1
Braucks, GR; Gadelha, MR; Naliato, EC; Tabet, AL; Violante, AH	1
Burshell, AL; Pathak, RD; Tran, TH	1
Gruszka, A; Kunert-Radek, J; Pawlikowski, M	2
Chang, JY; Kattah, JC; Orth, EH; Talkad, AV; Xu, MY	1
Murai, T; Murakami, N; Nagai, T; Obata, K; Sakazume, S; Sakuta, R; Takahashi, E; Yoshino, A	1
Couldwell, WT; Liu, JK	1
Stanhope, R; Torpiano, J; Vanderpump, M	1
Trifonov, I	1
Reuman, PD	1
Kwaśniewska, A; Semczuk, M; Skoczyński, M	1
Huang, PL; Lee, TC; Yang, LC	1
Abs, R; Verhelst, J	1
Howell, DL; Hudgins, RJ; Mazewski, CM; Meacham, LR; Wasilewski, K	1
Biswas, M; Davies, JS; Evans, LM; Jadon, D; McEwan, P; Rees, DA; Scanlon, MF; Smith, J	1
Delgrange, E; Jan, M; Perrin, G; Sassolas, G; Trouillas, J	1
Adler, I; Barsi, P; Czirják, S; Gergics, P; Jakab, C; Rácz, K; Varga, I	1
Hasegawa, H; Inui, T; Kubo, S; Tominaga, S; Yoshimine, T	1
Crosignani, PG	1
Bhansali, A; Chattopadhyay, A; Masoodi, SR	1
Bronstein, MD	2
Boulos, PT; Hamilton, DK; Laws, ER; Vance, ML	1
Gong, J; Wu, Z; Yu, C	1
Su, ZP; Wu, JS; Wu, ZB; Yu, CJ; Zheng, WM; Zhuge, QC	1
Bangash, MH; Clarke, DB; Holness, RO	1
Faridi, MM; Shah, D; Verma, S	1
Sugino, N	1
Colao, A; De Leo, M; Di Sarno, A; Guerra, E; Lombardi, G; Mentone, A	1
Pakawut, N; Panamonta, O	1
Mascarell, S; Sarne, DH	1
Abouzari, M; Aghazadeh, J; Hazrati, SM; Mohtarami, F; Rashidi, A	1
Cun, EH; Sun, W; Yan, CX; Yang, J; Yu, CJ; Zhang, HW	1
Arantes, HP; Feibelmann, TC; Fernandes, ML; Fonseca, AR; Gonçalves, FT; Jorge, PT	1
Clarke, DB; Imran, SA; Ur, E	1
Su, ZP; Wu, JS; Wu, ZB; Zheng, WM; Zhong, M; Zhuge, QC	1
Horikawa, F; Kawabata, Y; Miki, N; Miyake, H; Ono, M; Ueno, Y	1
Konopelska, S; Quinkler, M; Strasburger, CJ; Ventz, M	1
Casanueva, FF; Giustina, A; Mancini, T	1
Caldas, D; Cesar de Oliveira Naliato, E; Colao, A; Dutra Violante, AH; Fontes, R; Gomes de Souza, R; Guerra, E; Lamounier Filho, A; Rezende Loureiro, C; Schrank, Y; Sebastian, A; Vaisman, M	1
Chen, S; Kansra, S; Miller, M; Woodliff, J	1
Abs, R; Beckers, A; Verhelst, J	1
Garcia, MM; Kapcala, LP	1
Arita, N; Ekramullah, SM; Hayakawa, T; Ohnishi, T; Saitoh, Y; Taki, T	1
D'Angelo, V; Di Fazio, P; Dicembrino, F; Liuzzi, A; Scarabino, T; Scillitani, A; Vettori, PP	1
Nikolou, H; Thalassinos, N; Tsagarakis, S; Tsiganou, E; Tzavara, I	1
Jacobi, JM; Lloyd, HM; Willgoss, DA	1
Arita, J; Kimura, F; Kojima, Y; Kuwana, N	1
Beauregard, H; Serri, O; Somma, M	1
Jacobs, HS; Powell, M; Soule, SG	1
Howlett, TA; Khan, EG	1
Bauduceau, B; Ducorps, M; Eulry, F; Helie, C; Mayaudon, H; Riveline, JP	1
Rüedi, B	1
Cohen, AJ	1
Jacobs, HS; Soule, SG	1
Colao, A; Di Sarno, A; Di Somma, C; Ferone, D; Landi, ML; Merola, B; Nappi, C; Sarnacchiaro, F; Schettini, G; Selleri, A	1
Holdaway, IM; Wallace, EA	1
Akai, T; Hasan, S; Mizokawa, T; Nakada, Y; Nakagawa, H; Rettig, KJ; Wachtel, H; Yamaguchi, M	1
Ahn, SK; Chang, SN; Lee, SH	1
Calaf-Alsina, J; Espinós, JJ; Rodríguez-Espinosa, J; Webb, SM	1
Barziliai, S; Glaser, B; Nesher, Y	1
Brue, T; Cahen, S; Chabert-Orsini, V; Girard, N; Grisoli, F; Jaquet, P; Poncet, M; Raybaud, C	1
Benarous, R; Caccavelli, L; Dewailly, D; Enjalbert, A; Feron, F; Jaquet, P; Kordon, C; Morange, I; Rouer, E	1
Chandy, MJ; Cherian, AM; Kanagasbapathy, AS; Seshadri, MS; Sud, A; Thomas, J	1
Mithal, A; Trivedi, N	1
Archer, DJ; Bell, BA; Cook, RJ; Uttley, D; Wilkins, PR	1
Bermúdez, JA; Fonseca, ME; Morán, C; Ochoa, R; Tena, G; Zárate, A	1
Astorga, R; Cortés, A; García-Luna, PP; Leal-Cerro, A; Pereira, JL; Revuelta, M; Trujillo, F; Vaquero, F; Villamil, F	1
Aral, F; Barlas, O; Bayindir, C; Can, M; Hepgül, K; Kiriş, T; Sencer, E; Unal, F	1
Allen, SH; Braun, AL; McMurray, RW; Rodriguez, F; Walker, SE	1
Kleinberg, D; Kupersmith, MJ; Rosenberg, C	1
Ajossa, S; Cagnacci, A; Depau, GF; Guerriero, S; Mais, V; Melis, GB; Murgia, C; Paoletti, AM; Serra, GG	1
Endoh, M; Iouh, S; Nagai, M; Wakai, S	1
Bisset, S; Braun, M; Leclère, J; Morel-Jean, J; Pascal-Vigneron, V; Weryha, G	1
Wang, YC; Yang, DY	1
Buchfelder, M; Fahlbusch, R; Thierauf, P; Todo, T	1
Blackard, WG	1
Bakke, S; Bjøro, T; Brownell, J; Djøseland, O; Halse, J; Hansen, E; Jervell, J; Kvistborg, A	1
Assies, J; Bosch, DA; Hofland, LJ; Verhoeff, NP	1
Autz, A; Jean-Simon, ML; Peter, SA	1
Adriaanse, R; Bemelman, FJ; Brabant, G; Endert, E; Wiersinga, WM	1
David, R; Reggiardo, D; Sklar, C; Tyson, D	1
Yuang, BN; Zhong, Y	1
Crawford, PJ; Dewar, JH; Hall, K; Kendall-Taylor, P; Mbanya, JC; Mendelow, AD	1
Burkert, W; Rainov, NG	2
Brue, T; Chabert-Orsini, V; Cortesi, L; Girard, N; Jaquet, P; Maman, P; Raybaud, C	2
Brisman, MH; Fetell, MR; Post, KD	1
Bucht, E; Hulting, AL; Isberg, B; Sjöberg, HE; Tørring, O	1
Bemelman, FJ; van Royen, EA; Verhoeff, NP; Wiersinga, WM	1
Balsari, A; Boroni, F; Dal Toso, R; Giovanelli, M; Losa, M; Missale, C; Spano, P; Zanellato, A	1
de Kerdanet, M; Lebrethon, MC; Lecornu, M	1
Carballar, G; Espinosa de los Monteros, A; Obeid Layon, J; Parra Covarrubias, A	1
Avataneo, T; Camanni, F; Ciccarelli, E; Grottoli, S; Lancranjan, I; Miola, C	1
Benker, G; Haase, R; Jaspers, C; Lancranja, I; Orri-Fend, M; Pfingsten, H; Reinwein, D; Schulte, HM	1
Katayanagi, N; Miyachi, Y	1
Açikgöz, B; Erbengi, T; Ozcan, OE; Ozgen, T; Ruacan, S; Sumnu, M	1
Aversa, A; Baldelli, R; Fabbrini, A; Falaschi, P; Mori, F; Munizzi, MR; Nardone, MR; Rocco, A	1
Imamura, P; Lancranjan, I; Lengyel, AM; Mussio, W; Vieira, JG	1
van der Lely, AJ	1
Billaud, L; Cousin, I; Guilhaume, B; Luton, JP	1
Balsari, A; Boroni, F; Giovanelli, M; Losa, M; Missale, C; Spano, PF	1
Başkal, N; Cesur, V; Erdoğan, G; Kamel, N; Uysal, AR	1
Badenhoop, K; Rau, H; Usadel, KH	1
Cerbone, G; Colao, A; Di Sarno, A; Ferone, D; Landi, ML; Lombardi, G; Marzullo, P; Merola, B; Sarnacchiaro, F	1
Downey, DE; Feigenbaum, SL; Jaffe, RB; Wilson, CB	1
Delgrange, E; Donckier, J; Maiter, D	1
Kerner, W; Kreft, B; Peters, A	1
Check, JH; Shanis, BS	1
Camanni, F; Ciccarelli, E	1
de Herder, WW; Hofland, LJ; Lamberts, SW; van der Lely, AJ	1
Choudhury, SD; Goswami, A	1
von Werder, K	1
Balsari, A; Giovanelli, M; Losa, M; Missale, C; Sigala, S; Spano, PF	1
Gulino, A; Jaffrain-Rea, ML; Lunardi, P; Minniti, G; Tamburrano, G	1
Brue, T; Jaquet, P; Morange, I	1
al-Semaan, Y	1
Caccavelli, L; Enjalbert, A; Jaquet, P; Kordon, C; Morange-Ramos, I	1
Barlier, A; Brue, T; Enjalbert, A; Jaquet, P; Morange, I; Pellegrini, I	1
Brisman, MH; Katz, G; Post, KD	1
Chen, HH; Fagan, RH; Harrington, JF; Malchoff, CD; Rothfield, NF; Taxel, P; Waitzman, DM	1
Ferretti, E; Gulino, A; Jaffrain-Rea, ML; Minniti, G; Tamburrano, G	1
Angelberger, P; Asenbaum, S; Brücke, T; Czech, T; Deecke, L; Kornhuber, J; Luger, A; Pirker, W; Podreka, I; Riedl, M; Rössler, K	1
Andonova, K; Andreeva, M; Kalinov, K; Matrozov, P; Stoeva, I; Zacharieva, S	1
Loh, KC; Shlossberg, AH	1
Gerl, H; Knappe, G; Lehmann, R; Puhlmann, B; Rohde, W; Ventz, M	1
Molitch, ME; Thorner, MO; Wilson, C	1
Finardi, A; Fiorentini, C; Giovanelli, M; Losa, M; Missale, C; Sigala, S; Spano, P	1
Aono, T; Azuma, K; Irahara, M	1
Barlier, A; Enjalbert, A; Gunz, G; Jaquet, P; Pellegrini-Bouiller, I	1
Delgrange, E; Donckier, J; Maiter, D; Tourniaire, J; Trouillas, J	1
Jaquet, P	1
De Herder, WW; Hofland, LJ; Kros, MJ; Lamberts, SW; Uitterlinden, P; Van Koetsveld, PM; Van Uffelen, C; Visser-Wisselaar, HA; Waaijers, M; Zuyderwijk, J	1
Aron, DC; Justice, AC; King, JT	1
Asensio Egea, L; Hita Rosino, E; Hita Villaplana, G; López Cubillana, P; Rigabert Montiel, M; Server Falgás, G; Server Pastor, G	1
Pullan, PT; Walsh, JP	1
Kokunai, T; Tamaki, N; Yonezawa, K	1
Casanueva, F; Damjanovic, S; Dieguez, C; Djurovic, M; Ilic, L; Micic, D; Obradovic, S; Popovic, V; Simic, M	1
Crabbé, J; Delgrange, E; Donckier, J	1
Forsbach, G; Güitrón, A; Olivares, F; Vázquez, J	1
Alfonso Collado, JI; Domínguez Ugidos, LJ; Martínez Subías, J; Sancho Serrano, E; Urpegui García, A; Vallés Varela, H	1
Greenman, Y; Stern, N; Tordjman, K	1
Morrison, E	1
Brauner, R; Pinto, G; Trivin, C; Zerah, M	1
Cappa, M; Colao, A; Di Sarno, A; Facciolli, G; Landi, ML; Loche, S; Lombardi, G; Sarnacchiaro, F	1
Finkenstedt, G; Gasser, R; Höfle, G; Mohsenipour, I	1
Harada, K; Ishihara, T; Ito, H; Kashiwagi, S; Nishizaki, T; Setoguchi, M; Takahashi, M	1
Handa, J; Nakasu, S; Nakasu, Y; Shiino, A	1
McLaren, EH; Pollock, A	1
Nakamura, M; Saeki, N; Sunami, K; Yamaura, A	1
Buchfelder, M; Eiter, H; Komminoth, P; Popadić, A; Witzmann, A	1
Badawy, SZ; Chang, JK; Joy, SE; Marziale, JC; Rosenbaum, AE	1
Alatli, C; Aydin, Y; Can, SM; Gŭlkilik, A; Tŭrkmenoglu, O; Ziyal, I	1
Beń-Skowronek, I; Szewczyk, L; Witkowski, D	1
Black, PM; Garber, JR; Glickman, JN; Lidov, HG; McCowen, KC; Zervas, NT	1
de Herder, WW; Hofland, LJ; Lamberts, SW; Uitterlinden, P; van Koetsveld, PM; Waaijers, M; Zuijderwijk, J	1
Atkin, SL; Foy, PM; Hadden, DR; Leong, KS; MacFarlane, IA; Swift, AC	1
Dilouya, A; Nataf, F; Piketty, ML; Roux, FX	1
Acikgoz, B; Oruckaptan, HH; Ozcan, OE; Ozgen, T	1
Boquete, HR; Fideleff, HL; Giaccio, A; Sequera, A; Sobrado, P; Suárez, M	1
Colao, A; Di Sarno, A; Di Somma, C; Klain, M; Loche, S; Lombardi, G; Pietrosante, M; Pivonello, R; Salvatore, M	1
Hulting, AL; Melkersson, K	1
Donath, MY; Gross, DJ	1
Davies, JS; Rees, DA; Scanlon, MF	1
Bai, X; Hu, W; Jiang, X; Lei, T; Liu, K; Xue, D	1
Fukunaga, K; Kanasaki, H; Miyamoto, E; Miyazaki, K; Takahashi, K	1
De Nicolao, G; Faglia, G; Liberati, D; Pizzocaro, A; Sartorio, A; Veldhuis, JD	1
Djoumessi, S; Dong A Zok, F; Dongmo, L; Juimo, AG; Moukouri, E; Muna, WF; Nouedoui, C	1
Akamine, S; Hiramatsu, H; Miyamoto, T; Nishizawa, S; Sugiura, Y; Takehara, S; Yokota, N	1
Colman, PG; Hewage, UC; Kaye, A	1
Delgrange, E; Donckier, J; Guigard, MP; Jan, M; Jouanneau, E; Maiter, D; Perrin, G; Tourniaire, J; Trouillas, J	1
Davis, M; Prelevic, GM; Randeva, HS	1
Hall, K; James, RA; Jones, SE; Kendall-Taylor, P	1
Chazova, IE; Dmitriev, VV; Masenko, VP; Mychka, VB	1
Flitsch, J; Lüdecke, DK; Saeger, W; Stahnke, N; Wiebel, J	1
Freneau, E; Morange, I; Rohmer, V; Simonetta, C	1
Tammann, T	1
Agostini, S; Billeci, D; Conte, N; De Menis, E; Marton, E; Tramontin, P; Visentin, A	1
Gulati, MS; Kalra, S; Mittal, S; Sood, A	1
Barrali, E; Bonneville, F; Bonneville, J; Cattin, F; Lucas, X; Narboux, Y	1
Barkan, AL; Chandler, WF; Orrego, JJ	1
Fukui, M; Iwaki, T; Morioka, T; Nishio, S; Suzuki, S; Takeshita, I	1
Brabant, G; Schöfl, C; Schöfl-Siegert, B; von zur Mühlen, A	1
Barzaghi, ME; Beck-Peccoz, P; Bortolani, E; Corti, D; Forloni, F; Giovilli, M; Pecis, C; Preziosi, A	1
Asano, S; Kirino, T; Suzuki, I; Ueki, K	1
Arikan, E; Hatemi, H; Sabuncu, T; Tasan, E	1
Hagiwara, Y; Iwatsuki, K; Kadota, T; Moriuchi, S; Nakagawa, H; Yamada, M	1
Basso, A; Burdman, JA; Calabrese, MT; Guerra, LN	1
Cai, P; Dai, J; Pan, L; Wang, B; Wang, E; Zhang, N; Zhang, W	1
Arzberger, T; Müller, A; Pagotto, U; Saeger, W; Schaaf, L; Schumann, EM; Stalla, GK; Tatsch, K; Theodoropoulou, M; Trenkwalder, C; Winkelmann, J	1
Itoh, J; Kawai, K; Matsuno, A; Ogawa, K; Osamura, RY; Serizawa, A; Watanabe, K; Yamamoto, Y	1
Akada, K; Azuma, S; Haraoka, J; Nishioka, H	1
Colao, A; di Sarno, A; di Somma, C; Lombardi, G; Pivonello, R	1
Bousser, MG; El Amrani, M; Emperauger, B; Launay, JM; Levy, C; Massiou, H	1
Casanueva, F; Dieguez, C; Doknic, M; Medic-Stojanoska, M; Pekic, S; Popovic, V; Zarkovic, M	1
Brue, T; Figarella-Branger, D; Gunz, G; Jaquet, P; Morange, I	1
Audinot, V; Caccavelli, L; Cussac, D; Enjalbert, A; Jaquet, P; Pellegrini, I	1
Brue, T; Jaquet, P; Morange, I; Pellegrini, I; Priou, A	1
Caruso, E; Colao, A; Di Sarno, A; Di Somma, C; Lombardi, G; Merola, B; Sarnacchiaro, F	1
Huete, I; López, JM; Sapunar, J; Tagle, R	1
Caruso, E; Colao, A; de Divitiis, E; Lombardi, G; Merola, B; Pacilio, G; Panza, N; Schettini, G; Spaziante, R	1
Makowska, A; Soszyński, P; Słowińska-Srzednicka, J; Zgliczyński, S; Zgliczyński, W	1
Brownell, J; Brue, T; Dewailly, D; Enjalbert, A; Gunz, G; Jaquet, P; Morange, I; Pellegrini, I	1
Blackwell, RE	1
Bevan, JS; Burke, CW; Scanlon, MF; Webster, J	1
Cannavó, S; Curtó, L; De Natale, R; Li Calzi, L; Trimarchi, F	1
Demura, H; Demura, R; Isawa, M; Naruse, K; Naruse, M; Onoda, N; Yamakado, M	1
Hayashi, H; Kuroki, M; Nakajima, T; Tamura, T; Tanaka, R	1
Agnoli, AL; Bauer, T; Fassbender, WJ; Federlin, K; Hildebrandt, G; Mueller, HW; Roosen, K; Stracke, H	1
Eljamel, MS; Foy, PM; MacFarlane, IA; Swift, AC	1
Bonilla, A; Sancho, M	1
Bhoola, KD; Figueroa, CD; Jones, TH; Smith, CM	1
Berezin, M; Findler, G; Gutman, I; Horowitz, A; Tadmor, R	1
Amato, G; Carella, C; Costagliola, C; Mastropasqua, L	1
MacFarlane, IA; MacKenzie, JM; Petterson, T; Shaw, MD	1
Ach, K; Chadli-Chaieb, M; Chaieb, L; Kacem, M; Sfar, MH; Zebidi, A	1
Bhoola, KD; Cullen, DR; Figueroa, CD; Jones, TH; Smith, CM	1
García Calzado, MC; Ruiz Buendía, A	1
Lin, SQ	1
Kobras, G	1
Ahmed, M; al-Dossary, E; Woodhouse, NJ	1
Delahunt, JW; Feek, CM; Grebe, SK	1
Abs, R; Beckers, A; de Longueville, M; Flandroy, P; Lancranjan, I; Petrossians, P; Stadnik, T; Stevenaert, A	1
Kairam, R; Khandji, A; Levine, LS; Nagel, M; Nino, M; Oberfield, SE; Pang, S; Riddick, L	1
Caruso, E; Colao, A; Lancranjan, I; Lombardi, G; Merola, B; Sarnacchiaro, F; Schettini, G	1
Crosignani, P; D'Alberton, A; de Vincentiis, S; Ferrari, C; Mattei, AM; Paracchi, A	1
Chanson, P; Duranteau, L; Horlait, S; Kuhn, JM; Lavoinne, A; Lubetzki, J	1
Brownell, J; Lamberts, SW; van der Lely, AJ	1
Müller, OA; von Werder, K	1
Geyer, G; Knosp, E; Luger, A; Svoboda, T	1
Brownell, J; Crottaz, B; Gomez, F; Rey, F; Reymond, MJ; Siegel, RA; Uske, A	1
Kawano, T; Kuroda, S; Yonekawa, Y	1
Imai, Y; Ozawa, Y; Sawano, S; Shimizu, T; Shishiba, Y; Watanabe, T	1
Itoh, Y; Maeda, T; Mori, H; Moriwaki, K; Sawada, K	1
Alagna, S; Brunani, A; Cavagnini, F; Ginanni, A; Lancranjan, I; Maraschini, C; Masala, A; Moro, M; Rovasio, PP; Toja, P	1
Asensio Lahoz, LA; Correas Gomez, M; Fernandez Gomez, JM; Gutierrez Banos, JL; Hernandez Rodriguez, R; Martin Garcia, B; Masip, TC; Portillo Martin, JA	1
Garrido Pérez, M; López de la Torre Casares, M; Moreno Esteban, B; Rodríguez Poyo-Guerrero, P	1
De Min, C; Fabris, N; Faglia, G; Mocchegiani, E; Re, T; Travaglini, P	1
Brabant, G; Hesch, RD; Lancranjan, I; Schulz, A; Schuppert, F; Schürmeyer, T; von zur Mühlen, A	1
Briganti, F; Caruso, E; Colao, A; Lancranjan, I; Lombardi, G; Merola, B; Sarnacchiaro, F; Schettini, G	1
Domínguez Jiménez, A; Fletes Rabago, VM; Padilla Ruiz, R; Torres Farias, S	1
Banks, WA; Barrera, CM; Ruiz, AE	1
Brue, T; Dewailly, D; Hartemann, P; James-Deidier, A; Jaquet, P; Louvet, JP; Roger, P; Schaison, G; Schlienger, JL	1
Boquete, HR; Fideleff, HL; Holland, ME; Orlandi, AM; Wainstein, L	1
Bergström, M; Muhr, C	1
Kato, Y	1
af Trampe, E; Moberg, E; Werner, S; Wersäll, J	1
Ge, QS; Gu, CX; Lin, SQ; Wang, HL; Xu, L	1
Daemen, BJ; Doorenbos, H; Elsinga, PH; Paans, AM; Vaalburg, W; Zwertbroek, R	1
Goutelle, A; Perrin, G; Sassolas, G; Treluyer, C; Trouillas, J	1
Arita, K; Hirohata, T; Kurisu, K; Mukada, K; Onda, J; Takechi, A; Uozumi, T; Yano, T	1
Lancranjan, I	1
Hulting, AL; Lundberg, PO; Muhr, C; Werner, S	1
Croughs, RJ; van 't Verlaat, JW	1
Besser, M; Cunnah, D	1
Chen, GL; Jin, ZM; Shi, YF	1
Cohen, MJ; Holroyd, S	1
Diop, AG; Gueye, M; Kabre, A; Mauferon, JB; Ndiaye, IP; Ndiaye, MM	1
Yokoyama, M	1
Caruso, E; Colao, A; Lancranjan, I; Lombardi, G; Merola, B; Miletto, P; Schettini, G	1
Bergh, T; Larsson, SG; Rasmussen, C	2
Neal, JH; Weiss, MH	1
Cigognini, A; De Bernardi, B; Della Casa Alberighi, O; Honorati, C; Hu, C; Scorza, R; Togni, ME; Travaglini, P	1
De Bernardi, B; Honorati, MC; Hu, C; Radelli, L; Scorza, R; Togni, ME; Travaglini, P; Vanoli, M; Zanussi, C	1
Balabolkin, MI; Gerasimov, GA	1
Boulanger, JC	1
Bosma, NJ; Croughs, RJ; Hendriks, MJ; van 't Verlaat, JW	1
Kocijancic, A; Lancranjan, I; Prezelj, J; Vrhovec, I	1
Acosta, D; Cortés, A; García-Luna, PP; Leal-Cerro, A; Navarro, E; Pereira, JL; Revuelta, M; Santos, C; Trujillo, F; Villamil, F	1
Boghen, D; Lesser, RL; Odel, JG; Robbins, RJ; Zheutlin, JD	1
Gaver-Shavit, A; Gilboa, Y; Katzir, D; Ramot, Y; Rosenberg, T	1
Chevallier, P; Claustrat, B; Girod, C; Joly-Pharaboz, MO; Trouillas, J	1
Hildebrandt, G	1
Davis, JR; Heath, DA; Sheppard, MC	1
Herzog, A; Minne, H; Ziegler, R	1
Bevan, JS; Burke, CW	1
Miyakawa, I	1
Candrina, R; Tosoni, M	1
Besser, GM; Charlesworth, M; Grossman, A; Howlett, TA; Plowman, PN; Rees, LH; Savage, MO; Touzel, R; Wass, JA	1
Azad, N; Cernius, M; Emanuele, NV; Kirsteins, L; Lawrence, AM; Nayyar, R; Tentler, J	1
Bevan, JS; Hourihan, M; Peters, JR; Roberts, A; Sussman, J	1
Beniko, M; Ikota, A; Ikota, T; Mashio, Y; Mizumoto, H; Sato, S; Suzuki, S; Tashiro, T; Yamaguchi, O	1
Falsetti, L; Gastaldi, A; Pasinetti, E; Schivardi, MR	1
Christophis, P; Hildebrandt, G; Klug, N; Lancranjan, I; Laun, A; Schatz, H; Zierski, J	1
Koike, K; Miyake, A; Ohmichi, M; Tanizawa, O	1
Tiwary, CM	1
Costa, R; Grisoli, F; Jaquet, P; Pellegrini, I	1
Bertrand, P; Delivet, S; Enjalbert, A; Gunz, G; Jaquet, P; Jedynak, CP; Kordon, C; Peillon, F; Pellegrini, I; Rasolonjanahary, R	1
Aguiló, F; Baco, F; Otero, JR	1
Benabou, S; Bronstein, MD; Marino, R; Musolino, NR	1
Arrington, JA; Bryan, RN; Kumar, AJ; Yousem, DM; Zinreich, SJ	1
Adashi, EY; Katz, E; Schran, HF	1
Daru, J; Godó, G; Koloszár, S; Sas, M; Szilágyi, I	1
Budzilovitch, G; Cooper, P; Kleinberg, D; Kupersmith, MJ; Warren, FA	1
Bergström, K; Enoksson, P; Lundberg, PO; Muhr, C; Thuomas, KA	1
Hamester, U; Lüdecke, DK; Saeger, W	1
Arteaga, E; Fernández, C; Huete, I; López, JM; López, X	1
Ayala, AR; Grimaldo, J; López Espinoza, E; Verulo Reyes, TB; Villanueva, C	1
Arita, K; Ohta, M; Uozumi, T	1
Asa, SL; Duffy, AE; Kovacs, K	1
Hildebrandt, G; Schatz, H; Stracke, H	1
Maeda, T; Mori, H; Onishi, T; Saitoh, Y	1
Howng, SL; Wang, CJ	1
Artese, R; Boero, L; Cáceres Narizzano, O; Caputi, E; Kulczycki, A; Molocznik, I	1

Reviews

64 review(s) available for bromocriptine and Adenoma, Prolactin-Secreting, Pituitary

Article	Year
Evolution of a refractory prolactin-secreting pituitary adenoma into a pituitary carcinoma: report of a challenging case and literature review. BMC endocrine disorders, 2021, Oct-29, Volume: 21, Issue:1 Topics: Adult; Bromocriptine; Carcinoma; Craniotomy; Disease Progression; Female; Hormone Antagonists; Humans; Neoplasm Recurrence, Local; Neurosurgical Procedures; Pituitary Neoplasms; Prolactinoma; Radiosurgery; Reoperation; Spinal Cord Neoplasms	2021
The recurrence of prolactinoma after withdrawal of dopamine agonist: a systematic review and meta-analysis. BMC endocrine disorders, 2021, Nov-13, Volume: 21, Issue:1 Topics: Bromocriptine; Cabergoline; Deprescriptions; Dopamine Agonists; Humans; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactinoma	2021
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms. Frontiers in endocrinology, 2021, Volume: 12 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aminoquinolines; beta-Arrestins; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Filamins; Growth Hormone-Secreting Pituitary Adenoma; Humans; Lisuride; MicroRNAs; Pergolide; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2	2021
Treatment of Prolactinoma. Medicina (Kaunas, Lithuania), 2022, Aug-13, Volume: 58, Issue:8 Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Female; Humans; Pituitary Neoplasms; Pregnancy; Prolactinoma; Treatment Outcome	2022
How to manage intolerance to dopamine agonist in patients with prolactinoma. Pituitary, 2023, Volume: 26, Issue:2 Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma	2023
Diagnosis and Management of Pituitary Adenomas: A Review. JAMA, 2023, 04-25, Volume: 329, Issue:16 Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Child; Female; Human Growth Hormone; Humans; Hypopituitarism; Pituitary Neoplasms; Pregnancy; Prolactinoma	2023
A giant invasive macroprolactinoma with recurrent nasal bleeding as the first clinical presentation: case report and review of literature. BMC endocrine disorders, 2023, May-12, Volume: 23, Issue:1 Topics: Adult; Bromocriptine; Epistaxis; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Young Adult	2023
Prolactinomas in pregnancy: considerations before conception and during pregnancy. Pituitary, 2020, Volume: 23, Issue:1 Topics: Bromocriptine; Dopamine Agonists; Female; Humans; Pituitary Neoplasms; Pregnancy; Prolactinoma	2020
Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature. European journal of endocrinology, 2021, May-24, Volume: 185, Issue:1 Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Female; Humans; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactinoma; Tumor Burden; Young Adult	2021
Cabergoline versus bromocriptine for the treatment of giant prolactinomas: A quantitative and systematic review. Metabolic brain disease, 2018, Volume: 33, Issue:3 Topics: Adult; Bromocriptine; Cabergoline; Female; Humans; Hydranencephaly; Kidney Diseases; Male; Middle Aged; Prolactin; Prolactinoma; Sex Distribution; Treatment Outcome	2018
Management of Dopamine Agonist-Resistant Prolactinoma. Neuroendocrinology, 2019, Volume: 109, Issue:1 Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Humans; Pituitary Neoplasms; Prolactinoma	2019
[Endocrinologic diseases management during breastfeeding]. Medicina clinica, 2015, Jan-20, Volume: 144, Issue:2 Topics: Breast Feeding; Bromocriptine; Contraindications; Diabetes Mellitus, Type 2; Diet, Diabetic; Dopamine Agonists; Endocrine System Diseases; Estrogens; Female; Humans; Hyperprolactinemia; Hypoglycemic Agents; Hypopituitarism; Infant; Infant, Newborn; Insulin; Lactation; Milk, Human; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy in Diabetics; Prolactin; Prolactinoma; Puerperal Disorders; Thyroid Diseases	2015
Update on prolactinomas. Part 2: Treatment and management strategies. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2015, Volume: 22, Issue:10 Topics: Bromocriptine; Cabergoline; Disease Management; Dopamine Agonists; Drug Administration Schedule; Drug Resistance, Neoplasm; Ergolines; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neuroendoscopy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Sphenoid Sinus	2015
Dopaminergic drugs in type 2 diabetes and glucose homeostasis. Pharmacological research, 2016, Volume: 109 Topics: Acromegaly; Animals; Bromocriptine; Diabetes Mellitus, Type 2; Dopamine Agents; Glucose; Homeostasis; Humans; Parkinson Disease; Polymorphism, Genetic; Prolactinoma; Receptors, Dopamine D2	2016
Epistaxis and pituitary apoplexy due to ruptured internal carotid artery aneurysm embedded within pituitary adenoma. International journal of clinical and experimental pathology, 2015, Volume: 8, Issue:11 Topics: Aneurysm, Ruptured; Angiography, Digital Subtraction; Balloon Occlusion; Bromocriptine; Carotid Artery Diseases; Carotid Artery, Internal; Epistaxis; Hormone Antagonists; Hormone Replacement Therapy; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma; Radiosurgery; Tomography, X-Ray Computed; Treatment Outcome	2015
[Treatment of pituitary adenomas]. Orvosi hetilap, 2009, Sep-27, Volume: 150, Issue:39 Topics: Acromegaly; ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Aminoquinolines; Bromocriptine; Cushing Syndrome; Dopamine Agonists; Female; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Hypophysectomy; Incidental Findings; Male; Pituitary Hormones; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Radiosurgery; Receptors, Somatotropin; Somatostatin; Thyrotropin	2009
Clinical practice. Prolactinomas. The New England journal of medicine, 2010, Apr-01, Volume: 362, Issue:13 Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Visual Fields	2010
Prolactinoma in pregnancy. Best practice & research. Clinical endocrinology & metabolism, 2011, Volume: 25, Issue:6 Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fetus; Humans; Hyperprolactinemia; Infertility, Female; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	2011
Blurred vision during airline flight reveals prolactinoma. Optometry (St. Louis, Mo.), 2003, Volume: 74, Issue:3 Topics: Altitude; Aviation; Bromocriptine; Diagnostic Techniques, Endocrine; Dopamine Agonists; Female; Fundus Oculi; Hemianopsia; Humans; Magnetic Resonance Imaging; Middle Aged; Pituitary Neoplasms; Prolactinoma; Treatment Outcome; Visual Acuity; Visual Field Tests; Visual Fields	2003
Dopamine resistance of prolactinomas. Pituitary, 2003, Volume: 6, Issue:1 Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Humans; Pituitary Neoplasms; Prolactinoma	2003
Contemporary management of prolactinomas. Neurosurgical focus, 2004, Apr-15, Volume: 16, Issue:4 Topics: Bromocriptine; Cabergoline; Contraindications; Diagnosis, Differential; Ergolines; Female; Humans; Hypophysectomy; Magnetic Resonance Imaging; Male; Pituitary Diseases; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Radiosurgery; Remission Induction	2004
[Prolactinoma and pregnancy]. Akusherstvo i ginekologiia, 2004, Volume: 43 Suppl 2 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	2004
A rare case of pregnancy and delivery of a healthy neonate by a woman with microprolactinoma and review of the literature. Clinical and experimental obstetrics & gynecology, 2004, Volume: 31, Issue:4 Topics: Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Progesterone; Prolactinoma	2004
Hyperprolactinemia: pathophysiology and management. Treatments in endocrinology, 2003, Volume: 2, Issue:1 Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estrogens; Female; Humans; Hyperprolactinemia; Male; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Radiotherapy; Surgical Procedures, Operative	2003
Current treatment issues in female hyperprolactinaemia. European journal of obstetrics, gynecology, and reproductive biology, 2006, Apr-01, Volume: 125, Issue:2 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Pregnancy; Prolactinoma	2006
Prolactinomas and pregnancy. Pituitary, 2005, Volume: 8, Issue:1 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	2005
Pharmacologic resistance in prolactinoma patients. Pituitary, 2005, Volume: 8, Issue:1 Topics: Bromocriptine; Cabergoline; Cell Proliferation; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Resistance; Ergolines; Estrogens; Female; Humans; Male; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Dopamine D2	2005
[Amenorrhea-galactorrhea syndrome]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Jun-28, Volume: Suppl 2 Topics: Amenorrhea; Bromocriptine; Dopamine Agonists; Female; Galactorrhea; Hirsutism; Humans; Hyperprolactinemia; Hypophysectomy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Syndrome	2006
Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women. Nature clinical practice. Endocrinology & metabolism, 2006, Volume: 2, Issue:4 Topics: Adenoma; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Hyperprolactinemia; Male; Prolactin; Prolactinoma; Sex Characteristics	2006
[Discrepancy between IGF-1 and GH during 75 g oral glucose tolerance test measures to acromegaly screening in a patient with macroprolactinoma--case report and literature review]. Arquivos brasileiros de endocrinologia e metabologia, 2007, Volume: 51, Issue:3 Topics: Acromegaly; Bromocriptine; Glucose Tolerance Test; Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma	2007
Managing prolactin-secreting adenomas during pregnancy. Canadian family physician Medecin de famille canadien, 2007, Volume: 53, Issue:4 Topics: Adult; Bromocriptine; Female; Humans; Monitoring, Physiologic; Physicians, Family; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prenatal Care; Prognosis; Prolactinoma; Risk Assessment	2007
Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature. Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:1 Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dopamine Agonists; Dopamine Antagonists; Drug Antagonism; Female; Haloperidol; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Prolactinoma; Schizophrenia	2008
Hyperprolactinemia and prolactinomas. Endocrinology and metabolism clinics of North America, 2008, Volume: 37, Issue:1 Topics: Bromocriptine; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma	2008
Bromocriptine-induced cerebrospinal fluid fistula in patients with macroprolactinomas: report of three cases and a review of the literature. Surgical neurology, 1994, Volume: 41, Issue:6 Topics: Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Female; Fistula; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed	1994
[Massive intraventricular hemorrhage from prolactinoma during bromocriptine therapy: case report]. No shinkei geka. Neurological surgery, 1994, Volume: 22, Issue:7 Topics: Administration, Oral; Bromocriptine; Cerebral Hemorrhage; Cerebral Ventricles; Humans; Male; Middle Aged; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma	1994
[The treatment of prolactinomas during pregnancy and the lactation period]. Deutsche medizinische Wochenschrift (1946), 1996, Jan-05, Volume: 121, Issue:1-2 Topics: Bromocriptine; Dopamine Agonists; Female; Humans; Hypophysectomy; Lactation Disorders; Pituitary Irradiation; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	1996
[The therapy of a macroprolactinoma with the intramuscular application of a long-acting bromocriptine preparation]. Deutsche medizinische Wochenschrift (1946), 1996, Jul-05, Volume: 121, Issue:27 Topics: Adult; Bromocriptine; Delayed-Action Preparations; Dopamine Agonists; Female; Humans; Injections, Intramuscular; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction; Time Factors	1996
Diagnosis and drug therapy of prolactinoma. Drugs, 1996, Volume: 51, Issue:6 Topics: Bromocriptine; Dopamine Agonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Prolactinoma	1996
[Prolactinoma; diagnosis and treatment]. Nederlands tijdschrift voor geneeskunde, 1996, Jul-13, Volume: 140, Issue:28 Topics: Algorithms; Bromocriptine; Combined Modality Therapy; Dopamine Agonists; Hormone Antagonists; Humans; Pituitary Neoplasms; Prolactinoma	1996
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas. Hormone research, 1997, Volume: 47, Issue:4-6 Topics: Animals; Bromocriptine; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Nerve Growth Factors; Phenotype; Pituitary Neoplasms; Prolactinoma; Tumor Cells, Cultured	1997
[Bromocriptine loading test]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55 Suppl 2 Topics: Bromocriptine; Humans; Hyperprolactinemia; Pituitary Function Tests; Pituitary Gland, Anterior; Prolactin; Prolactinoma	1997
[Homeoproteins and pituitary adenoma]. Annales d'endocrinologie, 1997, Volume: 58, Issue:1 Topics: Adenoma; Animals; Bromocriptine; Dopamine Agonists; Drug Resistance, Neoplasm; Growth Hormone; Homeodomain Proteins; Humans; Mice; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Transcription Factors	1997
[Quinagolide and macroprolactinomas a progress?]. Annales d'endocrinologie, 1997, Volume: 58, Issue:2 Topics: Aminoquinolines; Bromocriptine; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	1997
[Invasive giant prolactinoma]. Acta otorrinolaringologica espanola, 1998, Volume: 49, Issue:2 Topics: Adult; Bromocriptine; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasms, Second Primary; Pituitary Neoplasms; Prolactinoma; Skull Base Neoplasms	1998
Diagnosis and treatment of prolactinomas. Advances in internal medicine, 1999, Volume: 44 Topics: Bromocriptine; Female; Fetus; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Neurosecretion; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma	1999
Malignant prolactinoma: case report and review of the literature. Surgical neurology, 1999, Volume: 51, Issue:1 Topics: Antineoplastic Agents; Bromocriptine; Chemotherapy, Adjuvant; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Hormone-Dependent; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiotherapy, Adjuvant; Tomography, X-Ray Computed	1999
Medical treatment of prolactinomas. Endocrinology and metabolism clinics of North America, 1999, Volume: 28, Issue:1 Topics: Animals; Bromocriptine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Neurosecretory Systems; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma	1999
CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas. Clinical endocrinology, 2000, Volume: 52, Issue:1 Topics: Adult; Bromocriptine; Cabergoline; Cerebrospinal Fluid Rhinorrhea; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed	2000
Prolactin secreting pituitary adenomas: analysis of 429 surgically treated patients, effect of adjuvant treatment modalities and review of the literature. Acta neurochirurgica, 1999, Volume: 141, Issue:12 Topics: Bromocriptine; Chemotherapy, Adjuvant; Combined Modality Therapy; Humans; Hypophysectomy; Injections, Intralesional; Neoplasm Invasiveness; Pituitary Irradiation; Pituitary Neoplasms; Prolactinoma; Radiotherapy, Adjuvant; Treatment Outcome	1999
Prolactinoma and pregnancy. BJOG : an international journal of obstetrics and gynaecology, 2000, Volume: 107, Issue:9 Topics: Bromocriptine; Dopamine Agonists; Female; Hormone Antagonists; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	2000
Dopamine receptor agonists for treating prolactinomas. Expert opinion on investigational drugs, 2002, Volume: 11, Issue:6 Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Ergot Alkaloids; Female; Humans; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma	2002
D2 dopaminergic receptors: normal and abnormal transduction mechanisms. Hormone research, 1992, Volume: 38, Issue:1-2 Topics: Arachidonic Acid; Bromocriptine; Calcium; Drug Resistance; GTP-Binding Proteins; Humans; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2; Signal Transduction	1992
Hyperprolactinemia. Evaluation and management. Endocrinology and metabolism clinics of North America, 1992, Volume: 21, Issue:1 Topics: Aminoquinolines; Animals; Bromocriptine; Dopamine Agents; Female; Humans; Hyperprolactinemia; Infertility; Ovary; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma	1992
Dopamine agonists and pituitary tumor shrinkage. Endocrine reviews, 1992, Volume: 13, Issue:2 Topics: Adenoma; Bromocriptine; Cell Division; Dopamine Agents; Female; Humans; Male; Meta-Analysis as Topic; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma	1992
Pathologic hyperprolactinemia. Endocrinology and metabolism clinics of North America, 1992, Volume: 21, Issue:4 Topics: Bromocriptine; Dopamine Antagonists; Female; Humans; Hyperprolactinemia; Hypothalamo-Hypophyseal System; Male; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma	1992
[Clinical aspects, morphology and biology of prolactinomas after therapy with dopamine agonists. A review of the literature]. Der Pathologe, 1992, Volume: 13, Issue:4 Topics: Animals; Bromocriptine; Combined Modality Therapy; Humans; Hypophysectomy; Microscopy, Electron; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactinoma	1992
[Hyperprolactinemia]. Zeitschrift fur arztliche Fortbildung, 1991, Feb-25, Volume: 85, Issue:3-4 Topics: Bromocriptine; Dopamine Agents; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Prolactinoma	1991
Positron emission tomography applied in the study of pituitary adenomas. Journal of endocrinological investigation, 1991, Volume: 14, Issue:6 Topics: Adenoma; Amino Acids; Animals; Bromocriptine; Dopamine Antagonists; Humans; Macaca mulatta; Methionine; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography; Receptors, Dopamine; Receptors, Dopamine D2; Tamoxifen; Tomography, Emission-Computed	1991
[Drug therapy of pituitary tumors]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Mar-10, Volume: 80, Issue:3 Topics: Bromocriptine; Cushing Syndrome; Cyproheptadine; Female; Humans; Male; Metyrapone; Octreotide; Pituitary Neoplasms; Prolactinoma	1991
Influence of pregnancy on the serum prolactin level following prolactinoma surgery. Acta endocrinologica, 1991, Volume: 125, Issue:3 Topics: Adult; Bromocriptine; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Pituitary Gland; Postpartum Period; Pregnancy; Pregnancy Complications; Prolactin; Prolactinoma; Radioimmunoassay; Remission, Spontaneous; Retrospective Studies	1991
The medical treatment of prolactin and growth hormone-secreting pituitary tumours. Acta neurochirurgica. Supplementum, 1990, Volume: 47 Topics: Bromocriptine; Dopamine Agents; Growth Hormone; Humans; Octreotide; Pituitary Neoplasms; Prolactin; Prolactinoma	1990
Management of prolactinoma. Lancet (London, England), 1990, Sep-15, Volume: 336, Issue:8716 Topics: Bromocriptine; Humans; Hyperprolactinemia; Male; Osteoporosis; Pituitary Neoplasms; Prolactinoma	1990
Management of prolactinomas. Clinical endocrinology, 1991, Volume: 34, Issue:3 Topics: Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	1991
[Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case]. Minerva ginecologica, 1989, Volume: 41, Issue:3 Topics: Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactin; Prolactinoma	1989

Trials

26 trial(s) available for bromocriptine and Adenoma, Prolactin-Secreting, Pituitary

Article	Year
Prolactinomas in infertile women: clinical and endocrine characteristics before and after 24 months of treatment with bromocriptine. Medical archives (Sarajevo, Bosnia and Herzegovina), 2013, Volume: 67, Issue:3 Topics: Adult; Bromocriptine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hormone Antagonists; Humans; Infertility, Female; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Time Factors; Treatment Outcome	2013
MicroRNA expression profile of bromocriptine-resistant prolactinomas. Molecular and cellular endocrinology, 2014, Volume: 395, Issue:1-2 Topics: Adult; Bromocriptine; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Male; MicroRNAs; Middle Aged; Prolactinoma; RNA, Neoplasm	2014
Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy. Pituitary, 2011, Volume: 14, Issue:3 Topics: Adiponectin; Adult; Body Weight; Bromocriptine; Dopamine Agonists; Female; Humans; Immunoassay; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 1; Lipids; Luminescent Measurements; Male; Middle Aged; Prolactin; Prolactinoma; Waist Circumference; Young Adult	2011
Circulating nitric oxide changes throughout the menstrual cycle in healthy women and women affected by pathological hyperprolactinemia on dopamine agonist therapy. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2002, Volume: 16, Issue:5 Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Estradiol; Female; Humans; Hyperprolactinemia; Luteal Phase; Menstrual Cycle; Nitric Oxide; Ovulation; Pituitary Neoplasms; Progesterone; Prolactinoma; Reference Values	2002
Medical therapy of macroprolactinomas in males: I. Prevalence of hypopituitarism at diagnosis. II. Proportion of cases exhibiting recovery of pituitary function. Pituitary, 2002, Volume: 5, Issue:4 Topics: Adrenocorticotropic Hormone; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Follicle Stimulating Hormone; Humans; Hypopituitarism; Luteinizing Hormone; Male; Middle Aged; Pergolide; Pituitary Function Tests; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Thyrotropin	2002
Bromocriptine treatment of invasive giant prolactinomas involving the cavernous sinus: results of a long-term follow up. Journal of neurosurgery, 2006, Volume: 104, Issue:1 Topics: Adolescent; Adult; Bromocriptine; Cavernous Sinus; Dopamine Agonists; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Treatment Outcome	2006
Quality of life in women with microprolactinoma treated with dopamine agonists. Pituitary, 2008, Volume: 11, Issue:3 Topics: Adult; Antineoplastic Agents; Brazil; Bromocriptine; Cabergoline; Case-Control Studies; Cross-Sectional Studies; Dopamine Agonists; Ergolines; Female; Health Status Indicators; Humans; Hyperprolactinemia; Middle Aged; Multivariate Analysis; Pituitary Neoplasms; Prolactin; Prolactinoma; Quality of Life; Reproducibility of Results; Surveys and Questionnaires; Treatment Outcome	2008
Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas. Clinical endocrinology, 1995, Volume: 42, Issue:6 Topics: Adenoma; Adolescent; Adult; Bromocriptine; Delayed-Action Preparations; Drug Administration Schedule; Growth Hormone; Humans; Injections, Intramuscular; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1995
Positive response to compound CV 205-502 in hyperprolactinemic patients resistant to or intolerant of bromocriptine. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1994, Volume: 8, Issue:3 Topics: Administration, Oral; Adult; Aminoquinolines; Bromocriptine; Delayed-Action Preparations; Dopamine Agonists; Drug Resistance; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors; Tomography, X-Ray Computed	1994
Long-acting repeatable bromocriptine in the treatment of patients with microprolactinoma intolerant or resistant to oral dopaminergics. Fertility and sterility, 1994, Volume: 62, Issue:5 Topics: Administration, Oral; Adult; Bromocriptine; Delayed-Action Preparations; Dopamine Agents; Drug Resistance; Female; Humans; Injections, Intravenous; Longitudinal Studies; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1994
Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502. The Journal of reproductive medicine, 1994, Volume: 39, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Bromocriptine; Dopamine Agonists; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome	1994
Long-term treatment of macroprolactinomas with CV 205-502. Acta endocrinologica, 1993, Volume: 128, Issue:4 Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Drug Tolerance; Erectile Dysfunction; Estradiol; Female; Humans; Libido; Longitudinal Studies; Male; Menstruation; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone; Visual Fields	1993
[Therapeutic efficacy of vaginal administration of bromocryptin in patients with hyperprolactinemia]. Ginecologia y obstetricia de Mexico, 1993, Volume: 61 Topics: Adult; Bromocriptine; Drug Evaluation; Female; Humans; Hyperprolactinemia; Infertility, Female; Menstruation Disturbances; Prolactinoma; Vagina	1993
Control of prolactin-secreting macroadenomas with parenteral, long-acting bromocriptine in 30 patients treated for up to 3 years. Clinical endocrinology, 1993, Volume: 38, Issue:2 Topics: Adolescent; Adult; Aged; Bromocriptine; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors	1993
Comparison among different dopamine-agonists of new formulation in the clinical management of macroprolactinomas. Hormone research, 1995, Volume: 44, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Bromocriptine; Dopamine Agonists; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Radioimmunoassay; Reagent Kits, Diagnostic; Tomography, X-Ray Computed	1995
Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine. European journal of endocrinology, 1996, Volume: 134, Issue:4 Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactinoma	1996
Comparison of the effects of cabergoline and bromocriptine on prolactin levels in hyperprolactinemic patients. Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:9 Topics: Adult; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome	2001
Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine. European journal of endocrinology, 2002, Volume: 147, Issue:1 Topics: Adolescent; Adult; Basal Metabolism; Body Weight; Bromocriptine; Dopamine; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Leptin; Male; Middle Aged; Obesity; Pituitary Neoplasms; Prolactin; Prolactinoma	2002
The efficacy and tolerability of CV 205-502 (a nonergot dopaminergic drug) in macroprolactinoma patients and in prolactinoma patients intolerant to bromocriptine. The Journal of clinical endocrinology and metabolism, 1991, Volume: 72, Issue:5 Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Tolerance; Female; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors	1991
[Treatment of prolactinoma with a new dopamine agonist]. Deutsche medizinische Wochenschrift (1946), 1991, Aug-16, Volume: 116, Issue:33 Topics: Adult; Aged; Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors	1991
Chronic treatment with parlodel LAR of patients with prolactin-secreting tumours. Different responsiveness of micro- and macroprolactinomas. Acta endocrinologica, 1991, Volume: 125, Issue:5 Topics: Adolescent; Adult; Aged; Bromocriptine; Dose-Response Relationship, Drug; Female; Humans; Injections; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1991
Efficacy and tolerability of a long-acting intramuscularly injectable depot preparation of bromocriptine: the results of a double blind study. Journal of endocrinological investigation, 1991, Volume: 14, Issue:6 Topics: Adolescent; Adult; Bromocriptine; Double-Blind Method; Female; Humans; Hyperprolactinemia; Injections, Intramuscular; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors	1991
[Alternative to bromocriptine (BEC) management in patients with prolactinoma and intolerance to oral BEC]. Ginecologia y obstetricia de Mexico, 1991, Volume: 59 Topics: Administration, Intravaginal; Adult; Bromocriptine; Drug Evaluation; Female; Humans; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Prospective Studies	1991
[Short-term effect of delayed-action injectable bromocriptine in macroprolactinoma. French multicenter study]. Annales d'endocrinologie, 1991, Volume: 52, Issue:4 Topics: Adult; Bromocriptine; Delayed-Action Preparations; Drug Administration Schedule; Drug Tolerance; Female; France; Humans; Injections, Intramuscular; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma	1991
Rapid and long-lasting suppression of prolactin secretion and shrinkage of prolactinomas after injection of long-acting repeatable form of bromocriptine (Parlodel LAR). Clinical endocrinology, 1990, Volume: 33, Issue:2 Topics: Adolescent; Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed; Visual Fields	1990
Light microscopical morphometry of prolactin secreting adenomas under treatment with dopamine agonists. Histology and histopathology, 1987, Volume: 2, Issue:2 Topics: Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Humans; Immunohistochemistry; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1987

Other Studies

356 other study(ies) available for bromocriptine and Adenoma, Prolactin-Secreting, Pituitary

Article	Year
Curcumin Sensitizes Prolactinoma Cells to Bromocriptine by Activating the ERK/EGR1 and Inhibiting the AKT/GSK-3β Signaling Pathway In Vitro and In Vivo. Molecular neurobiology, 2021, Volume: 58, Issue:12 Topics: Animals; Apoptosis; Bromocriptine; Cell Cycle; Cell Line, Tumor; Curcumin; Dopamine Agonists; Glycogen Synthase Kinase 3 beta; Mice; Pituitary Neoplasms; Prolactinoma; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction	2021
The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas. BMC endocrine disorders, 2021, Nov-23, Volume: 21, Issue:1 Topics: Animals; Apoptosis; Bromocriptine; Cell Line, Tumor; Disease Models, Animal; Dopamine Agonists; Drug Resistance; Estradiol; Female; Gene Expression Regulation; Mitogen-Activated Protein Kinase 11; Mitogen-Activated Protein Kinase 12; Mitogen-Activated Protein Kinase 13; Mitogen-Activated Protein Kinase 14; p38 Mitogen-Activated Protein Kinases; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Signal Transduction	2021
ACT001 reverses resistance of prolactinomas via AMPK-mediated EGR1 and mTOR pathways. Endocrine-related cancer, 2021, 12-13, Volume: 29, Issue:2 Topics: AMP-Activated Protein Kinases; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cabergoline; Drug Resistance, Neoplasm; Drug Synergism; Early Growth Response Protein 1; Furans; Humans; Pituitary Neoplasms; Prolactinoma; TOR Serine-Threonine Kinases	2021
Dopamine agonist for the rapid improvement of visual field defects in giant and macro-prolactinomas. Journal francais d'ophtalmologie, 2022, Volume: 45, Issue:5 Topics: Bromocriptine; Cabergoline; Dopamine Agonists; Female; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Vision Disorders; Visual Fields	2022
Surgery as a first-line option for prolactinomas. Expert review of endocrinology & metabolism, 2022, Volume: 17, Issue:6 Topics: Bromocriptine; Dopamine Agonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactinoma	2022
Italian Guidelines for the Management of Prolactinomas. Endocrine, metabolic & immune disorders drug targets, 2023, Volume: 23, Issue:12 Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Pituitary Neoplasms; Prolactin; Prolactinoma	2023
Remission of Recurrent Cochlear Hydrops Associated With Bromocriptine Treatment for Macroprolactinoma. American journal of audiology, 2019, Sep-13, Volume: 28, Issue:3 Topics: Adult; Audiometry, Pure-Tone; Bromocriptine; Cochlear Diseases; Diuretics; Furosemide; Glucocorticoids; Hearing Loss, Sensorineural; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Pituitary Neoplasms; Prolactinoma; Recurrence	2019
An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists. The Australian & New Zealand journal of obstetrics & gynaecology, 2020, Volume: 60, Issue:3 Topics: Abortion, Spontaneous; Adenoma; Adolescent; Adult; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Female; Humans; Infertility; Lactation; Pituitary Neoplasms; Postpartum Period; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Retrospective Studies; Young Adult	2020
Notable effect of bromocriptine monotherapy on macroprolactinoma with self-limited cerebrospinal fluid rhinorrhea. Polish archives of internal medicine, 2019, 12-23, Volume: 129, Issue:12 Topics: Adult; Anti-Bacterial Agents; Bromocriptine; Cefdinir; Cerebrospinal Fluid Rhinorrhea; Dopamine Agonists; Humans; Male; Pituitary Neoplasms; Poland; Prolactinoma; Treatment Outcome; Young Adult	2019
Giant Pituitary Adenoma Presenting with Foster-Kennedy Syndrome in a 21-Year Old Ethiopian Patient: A Rarely Reported Phenomenon: A Case Report. Ethiopian journal of health sciences, 2020, Volume: 30, Issue:2 Topics: Adult; Brain; Bromocriptine; Diagnosis, Differential; Dopamine Agonists; Ethiopia; Humans; Magnetic Resonance Imaging; Male; Optic Nerve Diseases; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Young Adult	2020
Rapid and dramatic glucose-lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinoma. Journal of diabetes investigation, 2021, Volume: 12, Issue:4 Topics: Blood Glucose; Bromocriptine; Diabetes Mellitus, Type 2; Dopamine Agonists; Female; Humans; Middle Aged; Prolactinoma	2021
Pimozide augments bromocriptine lethality in prolactinoma cells and in a xenograft model via the STAT5/cyclin D1 and STAT5/Bcl‑xL signaling pathways. International journal of molecular medicine, 2021, Volume: 47, Issue:1 Topics: Animals; bcl-X Protein; Bromocriptine; Cell Line, Tumor; Cyclin D1; Humans; Mice; Mice, Nude; Pimozide; Pituitary Neoplasms; Prolactinoma; Rats; Signal Transduction; STAT5 Transcription Factor; Xenograft Model Antitumor Assays	2021
Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas. International journal of medical sciences, 2020, Volume: 17, Issue:18 Topics: Adolescent; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cell Line, Tumor; Cyclin D1; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Hypophysectomy; Male; MAP Kinase Signaling System; Middle Aged; Neoplasm Recurrence, Local; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Receptors, Prolactin; Young Adult	2020
Genomic and transcriptomic analysis of pituitary adenomas reveals the impacts of copy number variations on gene expression and clinical prognosis among prolactin-secreting subtype. Aging, 2020, 12-19, Volume: 13, Issue:1 Topics: Adenoma; Adult; Aged; Bromocriptine; Cell Proliferation; DNA Copy Number Variations; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genomics; Growth Hormone-Secreting Pituitary Adenoma; Humans; Male; Middle Aged; Neoplasm Invasiveness; Oncogene Proteins v-erbB; Organelle Biogenesis; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma; Proto-Oncogene Proteins c-myc; Ribosomes; RNA-Seq; Signal Transduction; TOR Serine-Threonine Kinases; Transaminases; Whole Genome Sequencing; Young Adult	2020
Prolactinoma management: predictors of remission and recurrence after dopamine agonists withdrawal. Pituitary, 2017, Volume: 20, Issue:4 Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Prolactin; Prolactinoma; Retrospective Studies; Young Adult	2017
Pregnancy and Tumor Outcomes in Women with Prolactinoma. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2017, Volume: 125, Issue:10 Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Outcome Assessment, Health Care; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma; Retrospective Studies; Young Adult	2017
Best candidates for dopamine agonist withdrawal in patients with prolactinomas. Pituitary, 2017, Volume: 20, Issue:5 Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prolactinoma; Retrospective Studies; Young Adult	2017
Remarkable remission of an invasive giant prolactinoma under high-dose bromocriptine monotherapy. Polish archives of internal medicine, 2017, 08-09, Volume: 127, Issue:7-8 Topics: Adult; Antineoplastic Agents; Bromocriptine; Humans; Male; Pituitary Neoplasms; Prolactinoma; Treatment Outcome	2017
Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma. Endocrinologia, diabetes y nutricion, 2017, Volume: 64, Issue:10 Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bromocriptine; Cabergoline; Combined Modality Therapy; Dacarbazine; Drug Substitution; Ergolines; Fatal Outcome; Headache; Humans; Hyperprolactinemia; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma; Proton Therapy; Temozolomide	2017
Nonfunctional pancreatic endocrine tumor in the peripancreatic region in a Chinese patient with multiple endocrine neoplasia type 1. The Journal of international medical research, 2018, Volume: 46, Issue:2 Topics: Adult; Amino Acid Substitution; Bone and Bones; Bromocriptine; Female; Gene Expression; Hormone Antagonists; Humans; Multiple Endocrine Neoplasia Type 1; Mutation, Missense; Pain; Pancreatic Neoplasms; Prolactinoma; Proto-Oncogene Proteins; Tomography, X-Ray Computed	2018
Combination Treatment with Bromocriptine and Metformin in Patients with Bromocriptine-Resistant Prolactinomas: Pilot Study. World neurosurgery, 2018, Volume: 115 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Female; Humans; Male; Metformin; Pituitary Neoplasms; Prolactin; Prolactinoma	2018
Analysis of bromocriptine treatment in pregnant pituitary prolactinoma patients. Clinical and experimental obstetrics & gynecology, 2017, Volume: 44, Issue:2 Topics: Adult; Bromocriptine; China; Chorionic Gonadotropin; Drug Monitoring; Female; Fetal Development; Hormone Antagonists; Humans; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Progesterone; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome	2017
Impact of menopause on outcomes in prolactinomas after dopamine agonist treatment withdrawal. Clinical endocrinology, 2018, Volume: 89, Issue:3 Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Menopause; Postmenopause; Prolactin; Prolactinoma; Retrospective Studies; Withholding Treatment; Young Adult	2018
Giant Prolactinomas: Outcomes of Multimodal Treatments for 42 Cases with Long-Term Follow-Up. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2019, Volume: 127, Issue:5 Topics: Adult; Bromocriptine; Combined Modality Therapy; Dopamine Agonists; Female; Follow-Up Studies; Humans; Male; Outcome Assessment, Health Care; Pituitary Neoplasms; Prolactinoma; Retrospective Studies	2019
Macroprolactinomas: longitudinal assessment of biochemical and imaging therapeutic responses. Endocrine, 2018, Volume: 62, Issue:2 Topics: Adult; Biomarkers, Tumor; Bromocriptine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Tumor Burden; Young Adult	2018
Cabergoline for the treatment of bromocriptine-resistant invasive giant prolactinomas. Endocrine, 2018, Volume: 62, Issue:2 Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Drug Resistance, Neoplasm; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Failure; Tumor Burden; Young Adult	2018
Metformin inhibits growth and prolactin secretion of pituitary prolactinoma cells and xenografts. Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:12 Topics: AMP-Activated Protein Kinase Kinases; Animals; Apoptosis; Bromocriptine; Cell Proliferation; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Heterografts; Humans; Metformin; Mice; Phosphorylation; Pituitary Diseases; Prolactin; Prolactinoma; Protein Kinases; Receptors, Dopamine D2	2018
Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1. Journal of endocrinological investigation, 2019, Volume: 42, Issue:6 Topics: Adolescent; Adult; Animals; Apoptosis; Biomarkers, Tumor; Bromocriptine; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Male; Mice, Nude; MicroRNAs; Middle Aged; Pituitary Neoplasms; Prognosis; Prolactinoma; Tumor Cells, Cultured; Tumor Protein, Translationally-Controlled 1; Xenograft Model Antitumor Assays; Young Adult	2019
PGAM5-CypD pathway is involved in bromocriptine-induced RIP3/MLKL-dependent necroptosis of prolactinoma cells. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 111 Topics: Adolescent; Adult; Aged; Animals; Apoptosis; Bromocriptine; Cell Survival; Cyclophilins; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Mitochondrial Proteins; Necrosis; Phosphoprotein Phosphatases; Prolactinoma; Protein Kinases; Rats; Receptor-Interacting Protein Serine-Threonine Kinases; Signal Transduction; Young Adult	2019
miR-93-5p targets Smad7 to regulate the transforming growth factor-β1/Smad3 pathway and mediate fibrosis in drug-resistant prolactinoma. Brain research bulletin, 2019, Volume: 149 Topics: Adult; Bromocriptine; Drug Resistance, Neoplasm; Female; Fibrosis; Humans; Male; MicroRNAs; Middle Aged; Pituitary Neoplasms; Prolactinoma; Signal Transduction; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta1; Up-Regulation	2019
SUCCESSFUL TREATMENT OF A PROLACTINOMA (CASE REPORT). Georgian medical news, 2019, Issue:287 Topics: Bromocriptine; Dopamine Antagonists; Female; Galactorrhea; Humans; Infertility, Female; Menstruation Disturbances; Pituitary Neoplasms; Pregnancy; Pregnancy Outcome; Prolactin; Prolactinoma; Treatment Outcome; Young Adult	2019
Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively. Cell death & disease, 2019, 04-18, Volume: 10, Issue:5 Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Bromocriptine; Cabergoline; Cell Line, Tumor; Early Growth Response Protein 1; Extracellular Signal-Regulated MAP Kinases; Female; Mice; Mice, Nude; Microtubule-Associated Proteins; Pituitary Neoplasms; Prolactinoma; Proto-Oncogene Proteins c-akt; Rats; RNA Interference; RNA, Small Interfering; Signal Transduction; TOR Serine-Threonine Kinases	2019
Radiographic and Hormonal Regression in Prolactinomas: An Analysis of Treatment Failure. World neurosurgery, 2019, Volume: 129 Topics: Adult; Bromocriptine; Cabergoline; Disease Progression; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Sex Factors; Treatment Failure; Tumor Burden	2019
Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes. Internal medicine (Tokyo, Japan), 2019, Nov-01, Volume: 58, Issue:21 Topics: Amenorrhea; Bromocriptine; Diabetes Mellitus, Type 2; Female; Galactorrhea; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Young Adult	2019
Suppression of MMQ cells by fulvestrant: possible mechanism of action and potential application for bromocriptine-resistant prolactinomas. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2013, Volume: 20, Issue:5 Topics: Adult; Animals; beta Catenin; Bromocriptine; Cell Line; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Hormone Antagonists; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Rats; Young Adult	2013
[Effects of bromocriptine on the treatment of prolactinomas in male patients and its influences on their sexual function]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2013, Volume: 44, Issue:3 Topics: Adolescent; Adult; Aged; Bromocriptine; Erectile Dysfunction; Hormone Antagonists; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Sexual Dysfunction, Physiological; Testosterone; Young Adult	2013
[Visual outcome in patients with macroprolactinoma treated with dopamine agonists]. Revista medica de Chile, 2013, Volume: 141, Issue:6 Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prolactinoma; Retrospective Studies; Vision Disorders; Visual Acuity; Visual Fields; Young Adult	2013
Low levels of PRB3 mRNA are associated with dopamine-agonist resistance and tumor recurrence in prolactinomas. Journal of neuro-oncology, 2014, Volume: 116, Issue:1 Topics: Adolescent; Adult; Base Sequence; Bromocriptine; Chi-Square Distribution; Dopamine Agonists; Eye Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mucins; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactinoma; Proteins; RNA, Messenger; Salivary Proline-Rich Proteins; Young Adult	2014
Giant macroprolactinoma and pregnancy. Arquivos brasileiros de endocrinologia e metabologia, 2013, Volume: 57, Issue:7 Topics: Adult; Bromocriptine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Infant, Newborn; Infertility, Female; Male; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Treatment Outcome	2013
An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine. Lupus, 2014, Volume: 23, Issue:4 Topics: Bromocriptine; Female; Granulomatous Mastitis; Hormone Antagonists; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Pituitary Neoplasms; Prednisone; Prolactinoma; Recurrence; Young Adult	2014
Women with prolactinomas presented at the postmenopausal period. Endocrine, 2014, Volume: 47, Issue:3 Topics: Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Middle Aged; Pituitary Neoplasms; Postmenopause; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome	2014
Young female with acromegaloid features and pituitary macroadenoma: what is your diagnosis? Boletin de la Asociacion Medica de Puerto Rico, 2014, Volume: 106, Issue:1 Topics: Acanthosis Nigricans; Acromegaly; Adult; Bromocriptine; Cabergoline; Diagnosis, Differential; Ergolines; Female; Gastrointestinal Diseases; Hirsutism; Human Growth Hormone; Humans; Hyperprolactinemia; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prognathism; Prolactinoma	2014
A case of iatrogenic severe mitral regurgitation. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace, 2013, Volume: 80, Issue:3 Topics: Antineoplastic Agents; Bromocriptine; Cabergoline; Drug Therapy, Combination; Ergolines; Heart Valve Prosthesis; Heart Valve Prosthesis Implantation; Hormone Antagonists; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Pituitary Neoplasms; Prolactinoma; Treatment Outcome	2013
Endoscopic transsphenoidal treatment of a prolactinoma patient with brain and optic chiasmal herniations. The Journal of craniofacial surgery, 2014, Volume: 25, Issue:3 Topics: Bromocriptine; Dopamine Agonists; Endoscopy; Female; Hernia; Herniorrhaphy; Humans; Neurosurgical Procedures; Optic Chiasm; Pituitary Neoplasms; Prolactinoma; Sella Turcica; Sphenoid Bone; Treatment Outcome; Young Adult	2014
Anti-inflammatory effects of bromocriptine in a patient with autoimmune polyglandular syndrome type 2. Neuro endocrinology letters, 2014, Volume: 35, Issue:3 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Bromocriptine; Female; Humans; Pituitary Neoplasms; Polyendocrinopathies, Autoimmune; Prolactinoma	2014
The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas. Molecular and cellular endocrinology, 2015, Feb-15, Volume: 402 Topics: Adult; Animals; Antineoplastic Agents; Bromocriptine; Cell Line, Tumor; Dopamine Agonists; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Male; Middle Aged; Phosphorylation; Pituitary Neoplasms; Prolactinoma; Protein Processing, Post-Translational; Rats; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Young Adult	2015
[Pituitary apoplexy in a pregnant woman with cystic microprolactinoma]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2015, Volume: 62, Issue:4 Topics: Adult; Bromocriptine; Cabergoline; Combined Modality Therapy; Contraindications; Dopamine Agonists; Drug Substitution; Ergolines; Female; Headache; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypophysectomy; Infant, Newborn; Male; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Prolactinoma; Thyroxine; Vision Disorders	2015
A sensitive and rapid HPLC-MS/MS method for the quantitative determination of trace amount of bromocriptine in small clinical prolactinoma tissue. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2015, May-01, Volume: 989 Topics: Bromocriptine; Chromatography, High Pressure Liquid; Dopamine Agonists; Drug Monitoring; Humans; Pituitary Neoplasms; Prolactinoma; Sensitivity and Specificity; Tandem Mass Spectrometry	2015
[Analysis of treating prolactinoma patients with bromocriptine during pregnancy]. Zhonghua yi xue za zhi, 2015, Feb-17, Volume: 95, Issue:7 Topics: Adenoma; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Progesterone; Prolactin; Prolactinoma; Retrospective Studies	2015
Idiopathic hypertrophic pachymeningitis mimicking prolactinoma with recurrent vision loss. Hong Kong medical journal = Xianggang yi xue za zhi, 2015, Volume: 21, Issue:4 Topics: Adult; Bromocriptine; Diagnosis, Differential; Female; Hormone Antagonists; Humans; Meningitis; Pituitary Neoplasms; Prolactinoma; Vision Disorders	2015
Endonasal endoscopic transsphenoidal chiasmapexy using a clival cranial base cranioplasty for visual loss from massive empty sella following macroprolactinoma treatment with bromocriptine: case report. Journal of neurosurgery, 2016, Volume: 124, Issue:4 Topics: Bromocriptine; Craniotomy; Empty Sella Syndrome; Endoscopy; Female; Hormone Antagonists; Humans; Middle Aged; Nasal Cavity; Neurosurgical Procedures; Optic Chiasm; Pituitary Neoplasms; Prolactinoma; Skull Base; Sphenoid Bone; Treatment Outcome; Vision Disorders	2016
Sjögren's Syndrome Accompanied by Prolactinoma: a case report and literature review. International journal of rheumatic diseases, 2017, Volume: 20, Issue:11 Topics: Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bromocriptine; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Prolactinoma; Sjogren's Syndrome; Treatment Outcome; Young Adult	2017
Cost-Effectiveness Analysis of Microscopic and Endoscopic Transsphenoidal Surgery Versus Medical Therapy in the Management of Microprolactinoma in the United States. World neurosurgery, 2016, Volume: 87 Topics: Adult; Aged; Bromocriptine; Cabergoline; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Ergolines; Female; Health Care Costs; Hormone Antagonists; Humans; Hyperprolactinemia; Life Expectancy; Male; Medicare; Microsurgery; Middle Aged; Monte Carlo Method; Neuroendoscopy; Pituitary Neoplasms; Prolactinoma; Quality-Adjusted Life Years; Sphenoid Sinus; Time Factors; Treatment Outcome; United States	2016
Fifteen-Year-Old Female With Delayed Progression of Puberty and Visual Disturbances. Clinical pediatrics, 2016, Volume: 55, Issue:7 Topics: Adolescent; Bromocriptine; Diagnosis, Differential; Dopamine Agonists; Fatigue; Female; Humans; Magnetic Resonance Imaging; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Puberty, Delayed; Tomography, X-Ray Computed; Vision Disorders	2016
Dopamine agonist resistance-related endocan promotes angiogenesis and cells viability of prolactinomas. Endocrine, 2016, Volume: 52, Issue:3 Topics: Adolescent; Adult; Aged; Animals; Bromocriptine; Case-Control Studies; Cell Proliferation; Cell Survival; Cells, Cultured; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Male; Middle Aged; Neoplasm Proteins; Neovascularization, Pathologic; Pituitary Neoplasms; Prolactinoma; Proteoglycans; Rats; Young Adult	2016
Pituitary Prolactinoma Imaged by 99mTc-Sestamibi SPECT/CT in a Multiple Endocrine Neoplasia Type 1 Patient. Clinical nuclear medicine, 2016, Volume: 41, Issue:6 Topics: Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hypercalcemia; Hyperinsulinism; Hyperparathyroidism, Primary; Hyperprolactinemia; Magnetic Resonance Imaging; Multiple Endocrine Neoplasia Type 1; Parathyroid Glands; Parathyroidectomy; Pituitary Neoplasms; Prolactinoma; Radiopharmaceuticals; Single Photon Emission Computed Tomography Computed Tomography; Technetium Tc 99m Sestamibi	2016
Withdrawal of dopamine agonist therapy in prolactinomas: In which patients and when? Pituitary, 2016, Volume: 19, Issue:3 Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Deprescriptions; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Time Factors; Tumor Burden; Young Adult	2016
Prolactinomas: evolution after menopause. Archives of endocrinology and metabolism, 2016, Volume: 60, Issue:1 Topics: Adenoma; Adult; Bromocriptine; Cabergoline; Disease Progression; Dopamine Agonists; Ergolines; Female; Humans; Menopause; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome; Withholding Treatment	2016
Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas. Pituitary, 2016, Volume: 19, Issue:4 Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Child; Ergolines; Female; Galactorrhea; Headache; Hormone Antagonists; Humans; Male; Middle Aged; Neurosurgical Procedures; Pituitary Neoplasms; Prolactinoma; Sexual Dysfunction, Physiological; Treatment Outcome; Tumor Burden; Vision Disorders; Young Adult	2016
Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells. Cancer research and treatment, 2017, Volume: 49, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Bromocriptine; Cell Line, Tumor; Dopamine Agonists; Female; Gene Expression; Gene Knockdown Techniques; Humans; Male; Middle Aged; Neoplasm Grading; Pituitary Neoplasms; Prolactin; Prolactinoma; Proteolysis; S-Phase Kinase-Associated Proteins; Tumor Burden; Tumor Suppressor Protein p53; Ubiquitination	2017
Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists. Endocrine, 2017, Volume: 55, Issue:2 Topics: Adult; Aged; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hypogonadism; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sexual Dysfunction, Physiological	2017
SURGICAL OUTCOMES OF PROLACTINOMAS IN RECENT ERA: RESULTS OF A HETEROGENOUS GROUP. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2017, Volume: 23, Issue:1 Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurosurgical Procedures; Pituitary Neoplasms; Prolactinoma; Remission Induction; Retrospective Studies; Treatment Failure; Treatment Outcome; Tumor Burden; Young Adult	2017
10-year follow-up study comparing primary medical vs. surgical therapy in women with prolactinomas. Endocrine, 2017, Volume: 55, Issue:1 Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Humans; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome; Young Adult	2017
Prolactinoma and pregnancy - a series of cases including pituitary apoplexy. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2017, Volume: 37, Issue:3 Topics: Adult; Breast Feeding; Bromocriptine; Cesarean Section; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Infant, Newborn; Magnetic Resonance Imaging; Pituitary Apoplexy; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Retrospective Studies; Withholding Treatment	2017
Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes. Obstetrics and gynecology, 2017, Volume: 129, Issue:1 Topics: Adenoma; Adult; Amenorrhea; Antineoplastic Agents; Bromocriptine; Cabergoline; Case-Control Studies; Cesarean Section; Dopamine Agonists; Ergolines; Female; Galactorrhea; Humans; Incidence; Pituitary Neoplasms; Pre-Eclampsia; Preconception Care; Pregnancy; Pregnancy Complications, Neoplastic; Premature Birth; Prolactinoma; Prospective Studies; Stillbirth; United Kingdom; Vision Disorders; Young Adult	2017
MRI follow-up is unnecessary in patients with macroprolactinomas and long-term normal prolactin levels on dopamine agonist treatment. European journal of endocrinology, 2017, Volume: 176, Issue:3 Topics: Adult; Aminoquinolines; Belgium; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; France; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies	2017
An Economic Analysis of Bromocriptine Versus Trans-Sphenoidal Surgery for the Treatment of Prolactinoma. The Journal of craniofacial surgery, 2017, Volume: 28, Issue:4 Topics: Adult; Bromocriptine; Cost-Benefit Analysis; Dopamine Agonists; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Young Adult	2017
Case of the month. Prolactinoma. JAAPA : official journal of the American Academy of Physician Assistants, 2008, Volume: 21, Issue:5 Topics: Adult; Bromocriptine; Dopamine Agonists; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Prolactin; Prolactinoma; Radionuclide Imaging	2008
Pre-operative dopamine agonist therapy improves post-operative tumor control following prolactinoma resection. Pituitary, 2009, Volume: 12, Issue:3 Topics: Adult; Bromocriptine; Dopamine Agonists; Female; Humans; Male; Postoperative Period; Preoperative Care; Prolactin; Prolactinoma; Treatment Outcome	2009
[Cost-effectiveness analysis of two therapeutic methods for prolactinoma]. Zhonghua fu chan ke za zhi, 2008, Volume: 43, Issue:4 Topics: Adult; Bromocriptine; Cost-Benefit Analysis; Female; Humans; Hypophysectomy; Markov Chains; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Retrospective Studies; Treatment Outcome; Young Adult	2008
Clinical profile and long term follow up of children and adolescents with prolactinomas. Pituitary, 2009, Volume: 12, Issue:3 Topics: Adolescent; Amenorrhea; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Galactorrhea; Humans; Male; Pregnancy; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome; Young Adult	2009
Polycystic ovary syndrome and prolactinoma association. Internal medicine (Tokyo, Japan), 2009, Volume: 48, Issue:8 Topics: Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Polycystic Ovary Syndrome; Prolactinoma; Treatment Outcome	2009
Bromocriptine induces parapoptosis as the main type of cell death responsible for experimental pituitary tumor shrinkage. Toxicology and applied pharmacology, 2009, Oct-01, Volume: 240, Issue:1 Topics: Animals; Apoptosis; Bromocriptine; Cell Death; Male; MAP Kinase Kinase 2; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Pituitary Neoplasms; Prolactinoma; Protein Kinase C-delta; Rats; Rats, Wistar	2009
Non-surgical management of cystic prolactinomas. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2009, Volume: 16, Issue:11 Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Follow-Up Studies; Gadolinium; Hormones; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Young Adult	2009
Bilateral SUNCT-like headache in a patient with prolactinoma responsive to lamotrigine. The journal of headache and pain, 2009, Volume: 10, Issue:6 Topics: Bromocriptine; Calcium Channel Blockers; Female; Functional Laterality; Hormone Antagonists; Humans; Lamotrigine; Magnetic Resonance Imaging; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; SUNCT Syndrome; Treatment Outcome; Triazines; Young Adult	2009
Expression of D2RmRNA isoforms and ERmRNA isoforms in prolactinomas: correlation with the response to bromocriptine and with tumor biological behavior. Journal of neuro-oncology, 2010, Volume: 99, Issue:1 Topics: Adult; Bromocriptine; Drug Resistance, Neoplasm; Endoscopy; Female; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Prospective Studies; Protein Isoforms; Receptors, Dopamine D2; Receptors, Estrogen; Retrospective Studies; RNA, Messenger; Statistics as Topic; Statistics, Nonparametric; Young Adult	2010
Management of prolactinomas in Brazil: an electronic survey. Pituitary, 2010, Volume: 13, Issue:3 Topics: Brazil; Bromocriptine; Cabergoline; Data Collection; Dopamine Agonists; Ergolines; Female; Humans; Pregnancy; Prolactinoma	2010
Lactation associated with a pituitary tumour in a man. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2010, Apr-06, Volume: 182, Issue:6 Topics: Adult; Bromocriptine; Erectile Dysfunction; Female; Galactorrhea; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma	2010
Hyperprolactinemia: different clinical expression in childhood. Hormone research in paediatrics, 2010, Volume: 73, Issue:3 Topics: Adolescent; Amenorrhea; Bromocriptine; Child; Child, Preschool; Female; Humans; Hyperprolactinemia; Infant; Male; Polycystic Ovary Syndrome; Prolactinoma; Puberty, Delayed	2010
Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas. The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:6 Topics: Adult; Birth Weight; Bromocriptine; Cabergoline; Cohort Studies; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Infertility, Female; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Progesterone; Prolactin; Prolactinoma	2010
Rectal endometriosis and prolactinoma. Human reproduction (Oxford, England), 2010, Volume: 25, Issue:6 Topics: Adult; Anti-Infective Agents; Bromocriptine; Ciprofloxacin; Endometriosis; Female; Hormone Antagonists; Humans; Metronidazole; Prolactinoma; Rectal Diseases; Treatment Outcome	2010
The history of ergot of rye (Claviceps purpurea) III: 1940-80. The journal of the Royal College of Physicians of Edinburgh, 2010, Volume: 40, Issue:1 Topics: Bromocriptine; Claviceps; Dihydroergocryptine; Ergot Alkaloids; History, 20th Century; Humans; Lysergic Acid Diethylamide; Parkinson Disease; Prolactinoma; Receptors, Dopamine; Schizophrenia; Scotland; Secale	2010
BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists. Obesity (Silver Spring, Md.), 2011, Volume: 19, Issue:4 Topics: Adult; Aftercare; Aged; Blood Glucose; Body Composition; Body Mass Index; Body Weight; Bromocriptine; Cabergoline; Cholesterol, HDL; Cholesterol, LDL; Dopamine Agonists; Ergolines; Female; Humans; Insulin; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Metabolome; Middle Aged; Obesity; Prevalence; Prolactinoma; Waist Circumference; Weight Gain; Young Adult	2011
Management of pituitary macroprolactinoma in a 27-year-old male patient from Taiwan. Bratislavske lekarske listy, 2010, Volume: 111, Issue:4 Topics: Adult; Bromocriptine; Dopamine Agonists; Humans; Male; Pituitary Neoplasms; Prolactinoma	2010
Effect of dopaminergic drug treatment on surgical findings in prolactinomas. Pituitary, 2011, Volume: 14, Issue:1 Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Child; Dopamine Agents; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Young Adult	2011
Clinical management and outcome of 36 invasive prolactinomas treated with dopamine agonist. Journal of neuro-oncology, 2011, Volume: 104, Issue:1 Topics: Adult; Bromocriptine; Dopamine Agonists; Female; Headache; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Perceptual Disorders; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Sexual Dysfunction, Physiological; Visual Fields; Young Adult	2011
Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience. Pituitary, 2012, Volume: 15, Issue:1 Topics: Adolescent; Adult; Aged; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prolactinoma; Treatment Outcome; Young Adult	2012
A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas. Pituitary, 2012, Volume: 15, Issue:1 Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Prolactinoma	2012
Giant prolactinoma: where's the prolactin? Clinical neurology and neurosurgery, 2011, Volume: 113, Issue:9 Topics: Aged; Bromocriptine; Craniocerebral Trauma; Dopamine Agonists; Headache; Hormone Antagonists; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Male; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma	2011
No clinically significant valvular regurgitation in long-term cabergoline treatment for prolactinoma. Clinical endocrinology, 2012, Volume: 77, Issue:2 Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Cross-Sectional Studies; Echocardiography; Ergolines; Female; Humans; Male; Middle Aged; Prolactinoma; Retrospective Studies; Tricuspid Valve Insufficiency; Young Adult	2012
microRNA expression profile and differentially-expressed genes in prolactinomas following bromocriptine treatment. Oncology reports, 2012, Volume: 27, Issue:5 Topics: Adult; Antineoplastic Agents; Bromocriptine; Cluster Analysis; Dopamine Agonists; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Male; MicroRNAs; Middle Aged; Pituitary Neoplasms; Prolactinoma; Young Adult	2012
Increased prevalence of subclinical cardiac valve fibrosis in patients with prolactinomas on long-term bromocriptine and cabergoline treatment. European journal of endocrinology, 2012, Volume: 167, Issue:1 Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Pituitary Neoplasms; Prevalence; Prolactinoma; Prospective Studies	2012
[The effect of oxcarbamazepine on the clinical effectiveness of dopamine agonists in the treatment of prolactinoma]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2011, Volume: 64, Issue:4 Topics: Adult; Brain Injuries; Bromocriptine; Carbamazepine; Dopamine Agonists; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Pituitary Neoplasms; Prolactinoma	2011
Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas. Neuro endocrinology letters, 2012, Volume: 33, Issue:3 Topics: Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Heart Valve Diseases; Humans; Male; Middle Aged; Pituitary Neoplasms; Prevalence; Prolactinoma; Retrospective Studies; Risk Factors; Ultrasonography; Young Adult	2012
Medically treated prolactin-secreting pituitary adenomas: when should we operate? British journal of neurosurgery, 2013, Volume: 27, Issue:1 Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Postmenopause; Premenopause; Prolactinoma; Prospective Studies; Retrospective Studies; Sphenoid Bone; Time Factors; Treatment Failure	2013
Risk of thromboembolic events in patients with prolactinomas compared with patients with nonfunctional pituitary adenomas. Pituitary, 2013, Volume: 16, Issue:4 Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Ergolines; Female; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Thromboembolism; Young Adult	2013
Hyperprolactinemia in children: clinical features and long-term results. Journal of pediatric endocrinology & metabolism : JPEM, 2012, Volume: 25, Issue:11-12 Topics: Adolescent; Bromocriptine; Cabergoline; Child; Combined Modality Therapy; Ergolines; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Treatment Outcome	2012
Bromocriptine-induced brainstem angulation in a patient with invasive prolactinoma. The Journal of clinical endocrinology and metabolism, 2013, Volume: 98, Issue:3 Topics: Adult; Brain Stem; Bromocriptine; Empty Sella Syndrome; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma	2013
[Management of prolactinomas during pregnancy]. Zhonghua fu chan ke za zhi, 2002, Jun-18, Volume: 37, Issue:6 Topics: Adenoma; Adult; Bromocriptine; Combined Modality Therapy; Dopamine Agonists; Female; Humans; Infertility, Female; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactin; Prolactinoma; Retrospective Studies	2002
Successful treatment of a large macroprolactinoma with cabergoline during pregnancy. Pituitary, 2001, Volume: 4, Issue:3 Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	2001
Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawal. The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:8 Topics: Adolescent; Adult; Aged; Bromocriptine; Child; Cohort Studies; Female; Follow-Up Studies; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome	2002
Giant prolactinomas: clinical management and long-term follow up. Journal of neurosurgery, 2002, Volume: 97, Issue:2 Topics: Adult; Bromocriptine; Dopamine Agonists; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Outcome Assessment, Health Care; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sphenoid Sinus; Time Factors	2002
The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma. The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:10 Topics: Adult; Anastrozole; Aromatase Inhibitors; Bromocriptine; Cabergoline; Dopamine Agonists; Enzyme Inhibitors; Ergolines; Hormone Replacement Therapy; Humans; Magnetic Resonance Imaging; Male; Nitriles; Pituitary Neoplasms; Prolactin; Prolactinoma; Sexual Dysfunction, Physiological; Testosterone; Treatment Outcome; Triazoles	2002
[Results of treatment for male prolactinomas]. No shinkei geka. Neurological surgery, 2002, Volume: 30, Issue:12 Topics: Adult; Bromocriptine; Dopamine Agonists; Humans; Lisuride; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Apoplexy; Pituitary Neoplasms; Prolactin; Prolactinoma	2002
Efficacy and safety of bromocriptine in the treatment of macroprolactinomas. Annales d'endocrinologie, 2002, Volume: 63, Issue:6 Pt 1 Topics: Adult; Bromocriptine; Female; Follow-Up Studies; Hormone Antagonists; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Time Factors	2002
Prolactinomas, dopamine agonists and headache: two case reports. European journal of neurology, 2003, Volume: 10, Issue:2 Topics: Adult; Amenorrhea; Anti-Inflammatory Agents, Non-Steroidal; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Headache; Humans; Indomethacin; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography	2003
Pituitary adenomas in adolescent patients with multiple endocrine neoplasia type 1. Endocrine journal, 2002, Volume: 49, Issue:6 Topics: Adolescent; Bromocriptine; Female; Hormone Antagonists; Humans; Male; Multiple Endocrine Neoplasia Type 1; Pedigree; Pituitary Neoplasms; Prolactinoma	2002
Minimally invasive pituitary surgery in a hemorrhagic necrosis of adenoma during pregnancy. Minimally invasive neurosurgery : MIN, 2003, Volume: 46, Issue:3 Topics: Adult; Bromocriptine; Female; Hematoma; Hemorrhage; Hormone Antagonists; Humans; Minimally Invasive Surgical Procedures; Necrosis; Neurosurgical Procedures; Optic Nerve Neoplasms; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, Third; Prolactinoma	2003
Nerve growth factor restores p53 function in pituitary tumor cell lines via trkA-mediated activation of phosphatidylinositol 3-kinase. Molecular endocrinology (Baltimore, Md.), 2004, Volume: 18, Issue:1 Topics: Animals; Base Sequence; Bromocriptine; Cell Division; Cell Line, Tumor; DNA Primers; Humans; Mice; Nerve Growth Factor; Phosphatidylinositol 3-Kinases; Pituitary Neoplasms; Prolactinoma; Protein Conformation; Receptor, trkA; Reverse Transcriptase Polymerase Chain Reaction; Tumor Suppressor Protein p53	2004
Treatments of multi-invasive giant prolactinoma. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2004, Volume: 11, Issue:1 Topics: Aged; Bromocriptine; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Microscopy, Electron, Transmission; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiotherapy	2004
[Clinical and therapeutic aspects of prolactinoma in men]. Arquivos de neuro-psiquiatria, 2003, Volume: 61, Issue:4 Topics: Adolescent; Adult; Age of Onset; Biomarkers; Bromocriptine; Cabergoline; Chi-Square Distribution; Dopamine Agonists; Ergolines; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Pituitary Neoplasms; Prolactin; Prolactinoma; Statistics, Nonparametric; Treatment Outcome	2003
A case of dopamine agonists inhibiting pancreatic polypeptide secretion from an islet cell tumor. The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:2 Topics: Adenoma, Islet Cell; Bromocriptine; Chromogranin A; Chromogranins; Dopamine Agonists; Dose-Response Relationship, Drug; Female; Humans; Liver Neoplasms; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Pancreatic Polypeptide; Prolactinoma	2004
The effect of octreotide and bromocriptine on expression of a pro-apoptotic Bax protein in rat prolactinoma. Folia histochemica et cytobiologica, 2004, Volume: 42, Issue:1 Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Bromocriptine; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Immunohistochemistry; Male; Octreotide; Pituitary Neoplasms; Prolactin; Prolactinoma; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred F344	2004
Prolactinoma presenting as painful postganglionic Horner syndrome. Neurology, 2004, Apr-27, Volume: 62, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain; Bromocriptine; Cabergoline; Carotid Arteries; Dopamine Agonists; Ergolines; Horner Syndrome; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Migraine Disorders; Neoplasm Recurrence, Local; p-Hydroxyamphetamine; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction	2004
Bromocriptine treatment of prolactinoma restores growth hormone secretion and causes catch-up growth in a prepubertal child. European journal of pediatrics, 2004, Volume: 163, Issue:8 Topics: Adolescent; Bromocriptine; Dopamine Agonists; Growth Disorders; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prolactinoma	2004
The management of sellar masses: not all pituitary tumours require surgery for diagnosis and/or therapy. Journal of pediatric endocrinology & metabolism : JPEM, 2004, Volume: 17, Issue:4 Topics: Bromocriptine; Child; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Sella Turcica; Thyroxine; Treatment Outcome	2004
First reported pediatric case of systemic lupus erythematosus associated with prolactinoma. Arthritis and rheumatism, 2004, Volume: 50, Issue:11 Topics: Adolescent; Arthritis; Bromocriptine; Female; Hormone Antagonists; Humans; Inflammation Mediators; Lupus Erythematosus, Systemic; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome	2004
Treatment of empty sella syndrome with ventriculoperitoneal shunt. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2005, Volume: 12, Issue:2 Topics: Adult; Bromocriptine; Empty Sella Syndrome; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactinoma; Ventriculoperitoneal Shunt	2005
The use of high-dose daily cabergoline in an adolescent patient with macroprolactinoma. Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:6 Topics: Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Treatment Outcome	2005
Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas. Clinical endocrinology, 2005, Volume: 63, Issue:1 Topics: Adolescent; Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome	2005
Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance. Acta neurochirurgica, 2005, Volume: 147, Issue:7 Topics: Adult; Aged; Bromocriptine; Dopamine Agonists; Drug Resistance; Female; Humans; Hypophysectomy; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Mitotic Index; Neoplasm Invasiveness; Neoplasm Staging; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sex Factors	2005
Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2005, Volume: 20, Issue:6 Topics: Adult; Bromocriptine; Combined Modality Therapy; Diagnosis, Differential; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma	2005
Endonasal endoscopic transsphenoidal chiasmapexy with silicone plates for empty sella syndrome: technical note. Neurologia medico-chirurgica, 2005, Volume: 45, Issue:8 Topics: Adult; Aged; Atrophy; Bromocriptine; Empty Sella Syndrome; Endoscopy; Female; Hormone Antagonists; Humans; Male; Nasal Cavity; Neurosurgical Procedures; Optic Chiasm; Prolactinoma; Prostheses and Implants; Sella Turcica; Silicones; Treatment Outcome; Vision Disorders	2005
Long-term efficacy of bromocriptine in macroprolactinomas and giant prolactinomas in men. Pituitary, 2005, Volume: 8, Issue:2 Topics: Adolescent; Adult; Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Pituitary Function Tests; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Visual Fields	2005
Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists. Pituitary, 2005, Volume: 8, Issue:1 Topics: Adult; Aged; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma; Remission Induction; Retrospective Studies; Treatment Outcome	2005
Combined treatment of invasive giant prolactinomas. Pituitary, 2005, Volume: 8, Issue:1 Topics: Adolescent; Adult; Bromocriptine; Combined Modality Therapy; Craniotomy; Dopamine Agonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome	2005
Brain & chiasmal herniations into sella after medical treatment of prolactinoma. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2006, Volume: 33, Issue:2 Topics: Aged; Bromocriptine; Encephalocele; Frontal Lobe; Hemianopsia; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Neurosurgical Procedures; Optic Chiasm; Pituitary Neoplasms; Postoperative Complications; Prolactin; Prolactinoma; Sella Turcica	2006
Breastfeeding a baby with mother on Bromocripine. Indian journal of pediatrics, 2006, Volume: 73, Issue:5 Topics: Adult; Breast Feeding; Bromocriptine; Counseling; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Infant Nutritional Physiological Phenomena; Infant, Newborn; Pituitary Neoplasms; Prolactinoma	2006
Potential for long-term remission of microprolactinoma after withdrawal of dopamine-agonist therapy. Nature clinical practice. Endocrinology & metabolism, 2006, Volume: 2, Issue:3 Topics: Adolescent; Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	2006
Galactorrhea in a 14-year-old girl. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2006, Volume: 89, Issue:8 Topics: Adolescent; Bromocriptine; Diagnosis, Differential; Female; Galactorrhea; Hormone Antagonists; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Prolactinoma	2006
Clinical presentation and response to therapy in patients with massive prolactin hypersecretion. Pituitary, 2007, Volume: 10, Issue:1 Topics: Adult; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone	2007
Immunotherapy of prolactinoma with a T helper 1 activator adjuvant and autoantigens: a case report. Neuroimmunomodulation, 2006, Volume: 13, Issue:4 Topics: Adjuvants, Immunologic; Adult; Autoantigens; Bromocriptine; Female; Hormone Antagonists; Humans; Immunotherapy; Lymphocyte Activation; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactin; Prolactinoma; Th1 Cells	2006
[Bromocriptine treatment of invasive giant prolactinomas prior to comprehensive treatments: results of a long-term follow up]. Zhonghua wai ke za zhi [Chinese journal of surgery], 2006, Nov-15, Volume: 44, Issue:22 Topics: Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Hormone Antagonists; Humans; Hypophysectomy; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Radiosurgery; Retrospective Studies; Time Factors; Treatment Outcome	2006
Five years follow-up of invasive prolactinomas with special reference to the control of cavernous sinus invasion. Pituitary, 2008, Volume: 11, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Bromocriptine; Cavernous Sinus; Chemotherapy, Adjuvant; Dopamine Agonists; Empty Sella Syndrome; Female; Follow-Up Studies; Hernia; Humans; Magnetic Resonance Imaging; Male; Microsurgery; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Optic Chiasm; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiotherapy, Adjuvant; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult	2008
Remarkable effects of cabergoline in a patient with huge prolactinoma resistant to high-dose bromocriptine: case report. Surgical neurology, 2008, Volume: 69, Issue:1 Topics: Adult; Antineoplastic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Humans; Male; Pituitary Neoplasms; Prolactinoma; Treatment Outcome	2008
Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells. Endocrinology, 2008, Volume: 149, Issue:8 Topics: Animals; Antineoplastic Agents; Apoptosis; Bromocriptine; Cell Proliferation; Clone Cells; Curcumin; Cyclin D3; Cyclins; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Phosphorylation; Pituitary Hormones; Pituitary Neoplasms; Prolactinoma; Rats; Retinoblastoma Protein; Time Factors; Tumor Cells, Cultured	2008
The effect of naloxone and metoclopramide on the secretion of luteinizing hormone in a hyperprolactinemic hypogonadotropic postmenopausal woman. Fertility and sterility, 1995, Volume: 64, Issue:5 Topics: Aged; Bromocriptine; Dopamine Agonists; Dopamine Antagonists; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Hypogonadism; Injections, Intravenous; Luteinizing Hormone; Metoclopramide; Naloxone; Narcotic Antagonists; Pituitary Neoplasms; Postmenopause; Prolactin; Prolactinoma	1995
Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy. Journal of endocrinological investigation, 1995, Volume: 18, Issue:6 Topics: Amenorrhea; Bromocriptine; Estradiol Congeners; Female; Hormone Antagonists; Humans; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed	1995
Effects of bromocriptine on staining indices of Ki-67 and proliferating cell nuclear antigen, and nucleolar organizer region number in pituitary adenomas. Neurologia medico-chirurgica, 1995, Volume: 35, Issue:4 Topics: Adult; Bromocriptine; Female; Humans; Immunohistochemistry; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Proliferating Cell Nuclear Antigen; Treatment Outcome	1995
In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas. The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:8 Topics: Adult; Benzamides; Brain; Bromocriptine; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Pyrrolidines; Receptors, Dopamine; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	1995
DNA synthesis by pituitary tumours, with reference to plasma hormone levels and to effects of bromocriptine. Clinical endocrinology, 1995, Volume: 43, Issue:1 Topics: Acromegaly; Adolescent; Adult; Aged; Bromocriptine; Child; DNA, Neoplasm; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1995
Dopamine responsiveness of human prolactinoma cells as determined by the reverse hemolytic plaque assay. Endocrine journal, 1995, Volume: 42, Issue:3 Topics: Adolescent; Adult; Bromocriptine; Dopamine; Female; Hemolytic Plaque Technique; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1995
Prolactinoma. Current therapy in endocrinology and metabolism, 1994, Volume: 5 Topics: Bromocriptine; Female; Humans; Male; Menstruation; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma	1994
Prolactinomas resistant to dopamine agonists: insights into pathogenesis and therapy. Current opinion in obstetrics & gynecology, 1994, Volume: 6, Issue:4 Topics: Adult; Bromocriptine; Drug Resistance; Female; Humans; Pituitary Neoplasms; Prolactinoma	1994
Two macroprolactinomas presenting with neurological signs. Journal of the Royal Society of Medicine, 1995, Volume: 88, Issue:2 Topics: Adult; Bromocriptine; Female; Hemiplegia; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed; Vision Disorders; Visual Fields	1995
[Do articular manifestations appear in prolactinomas?]. Presse medicale (Paris, France : 1983), 1995, Apr-08, Volume: 24, Issue:14 Topics: Adult; Arthritis; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies	1995
[Diagnostic and therapeutic approach to hyperprolactinemia]. Revue medicale de la Suisse romande, 1995, Volume: 115, Issue:5 Topics: Amenorrhea; Anovulation; Bromocriptine; Diagnostic Imaging; Female; Galactorrhea; Humans; Hyperprolactinemia; Menstruation Disturbances; Pituitary Neoplasms; Prolactinoma	1995
Bromocriptine for prolactinoma-related dissociative disorder and depression. Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:2 Topics: Bromocriptine; Depressive Disorder; Dissociative Disorders; Female; Follicle Stimulating Hormone; Humans; Hyperprolactinemia; Luteinizing Hormone; Middle Aged; Neurocognitive Disorders; Pituitary Neoplasms; Prolactin; Prolactinoma	1995
Prolactinomas: present day management. British journal of obstetrics and gynaecology, 1995, Volume: 102, Issue:3 Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	1995
Treatment of macroprolactinomas at Auckland Hospital 1975-91. The New Zealand medical journal, 1995, Feb-22, Volume: 108, Issue:994 Topics: Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; New Zealand; Pituitary Neoplasms; Postoperative Complications; Prolactinoma; Retrospective Studies; Treatment Outcome	1995
Terguride as a new anti-hyperprolactinemic agent: characterization in rats and dogs in comparison with bromocriptine. Japanese journal of pharmacology, 1993, Volume: 63, Issue:3 Topics: Animals; Bromocriptine; Dogs; Dopamine Agents; Estradiol; Female; Glutathione; Hyperprolactinemia; Lactation; Lisuride; Luteinizing Hormone; Male; Motor Activity; Pituitary Neoplasms; Prolactinoma; Rats; Rats, Wistar; Receptors, Dopamine D2; Reserpine; Stereotyped Behavior; Vomiting	1993
Lichen sclerosus associated with prolactinoma. The British journal of dermatology, 1994, Volume: 131, Issue:3 Topics: Adult; Bromocriptine; Female; Humans; Lichenoid Eruptions; Pituitary Neoplasms; Prolactinoma; Vulvar Diseases	1994
3D-FT thin sections MRI of prolactin-secreting pituitary microadenomas. Neuroradiology, 1994, Volume: 36, Issue:5 Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma	1994
Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas. Neuroendocrinology, 1994, Volume: 60, Issue:3 Topics: Adenoma; Adenylyl Cyclases; Adolescent; Adult; Alternative Splicing; Base Sequence; Bromocriptine; Drug Resistance; Female; Gene Expression; Growth Hormone; Humans; Male; Molecular Sequence Data; Pituitary Neoplasms; Polymerase Chain Reaction; Prolactinoma; Receptors, Dopamine D2	1994
Hyperprolactinemia in women--a series of 71 cases. The Journal of the Association of Physicians of India, 1993, Volume: 41, Issue:11 Topics: Adult; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Hypophysectomy; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prolactinoma	1993
Macroprolactinoma expansion during pregnancy. The Journal of the Association of Physicians of India, 1993, Volume: 41, Issue:11 Topics: Adult; Bromocriptine; Female; Humans; Infant, Newborn; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Tomography, X-Ray Computed	1993
Prolactinomas in men masquerading as invasive skull base tumours. British journal of neurosurgery, 1994, Volume: 8, Issue:1 Topics: Adolescent; Adult; Bromocriptine; Combined Modality Therapy; Diagnosis, Differential; Humans; Hypophysectomy; Immunoenzyme Techniques; Male; Middle Aged; Pituitary Gland; Pituitary Irradiation; Pituitary Neoplasms; Postoperative Complications; Prolactin; Prolactinoma; Tomography, X-Ray Computed	1994
Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy. Archives of medical research, 1994,Spring, Volume: 25, Issue:1 Topics: Adolescent; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Hyperprolactinemia; Lisuride; Molecular Weight; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography	1994
[Long-acting and repeatable dose bromocriptine in the prolonged treatment of prolactinoma]. Medicina clinica, 1994, Jun-11, Volume: 103, Issue:2 Topics: Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors; Vision Disorders	1994
Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. The Journal of rheumatology, 1994, Volume: 21, Issue:5 Topics: Adult; Autoimmune Diseases; Bromocriptine; Female; Humans; Hyperprolactinemia; Lupus Erythematosus, Systemic; Pituitary Neoplasms; Prolactinoma; Radiography; Time Factors	1994
Visual loss in pregnant women with pituitary adenomas. Annals of internal medicine, 1994, Oct-01, Volume: 121, Issue:7 Topics: Acromegaly; Adenoma; Adult; Bromocriptine; Cohort Studies; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Risk Factors; Tomography, X-Ray Computed; Vision Disorders; Visual Fields	1994
Shrinkage of pituitary PRL-secernent adenoma after short-term treatment with bromocriptine long-acting repeatable injections. Clinical and experimental obstetrics & gynecology, 1994, Volume: 21, Issue:2 Topics: Adolescent; Adult; Bromocriptine; Delayed-Action Preparations; Female; Humans; Injections; Pituitary Neoplasms; Prolactin; Prolactinoma	1994
[Rhinorrhea and otorrhea: rare complications of the medical treatment in invasive prolactinomas]. Annales d'endocrinologie, 1994, Volume: 54, Issue:5 Topics: Adult; Bromocriptine; Cerebrospinal Fluid Otorrhea; Cerebrospinal Fluid Rhinorrhea; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma	1994
Bromocriptine treatment of postoperative prolactinoma patients. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1994, Volume: 53, Issue:6 Topics: Adolescent; Adult; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma	1994
Immunohistochemical expression of protein kinase C type III in human pituitary adenomas. Neurosurgery, 1993, Volume: 32, Issue:4 Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Cushing Syndrome; Dopamine Agents; Female; Humans; Immunohistochemistry; Isoenzymes; Male; Middle Aged; Pituitary Neoplasms; Preoperative Care; Prolactinoma; Protein Kinase C	1993
Edema--an infrequently recognized complication of bromocriptine and other ergot dopaminergic drugs. The American journal of medicine, 1993, Volume: 94, Issue:4 Topics: Aminoquinolines; Bromocriptine; Dopamine Agents; Edema; Humans; Male; Middle Aged; Pergolide; Pituitary Neoplasms; Prolactinoma	1993
Intracranial dissemination of a macroprolactinoma. Clinical endocrinology, 1993, Volume: 38, Issue:5 Topics: Aminoquinolines; Brain Neoplasms; Bromocriptine; Combined Modality Therapy; Drug Therapy, Combination; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Radiotherapy Dosage; Somatostatin	1993
Bromocriptine-induced schizophrenia. Journal of the National Medical Association, 1993, Volume: 85, Issue:9 Topics: Bromocriptine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Schizophrenia	1993
Pulsatile thyrotropin and prolactin secretion in a patient with a mixed thyrotropin- and prolactin-secreting pituitary adenoma. European journal of endocrinology, 1994, Volume: 130, Issue:2 Topics: Adenoma; Adult; Bromocriptine; Circadian Rhythm; Cluster Analysis; Follow-Up Studies; Humans; Hyperthyroidism; Male; Octreotide; Pituitary Neoplasms; Prolactin; Prolactinoma; Pulsatile Flow; Thyrotropin; Visual Acuity	1994
Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy. American journal of diseases of children (1960), 1993, Volume: 147, Issue:10 Topics: Adolescent; Bromocriptine; Child; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Prolactinoma	1993
[Nursing care of pituitary prolactinoma with bromocriptine]. Zhonghua hu li za zhi = Chinese journal of nursing, 1993, Volume: 28, Issue:5 Topics: Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactinoma	1993
Rapid resolution of visual abnormalities with medical therapy alone in patients with large prolactinomas. British journal of neurosurgery, 1993, Volume: 7, Issue:5 Topics: Adult; Bromocriptine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Vision Disorders; Visual Acuity; Visual Fields	1993
Malignant growth of a recurrent macroprolactinoma after radiation therapy. Neurochirurgia, 1993, Volume: 36, Issue:5 Topics: Bromocriptine; Cell Transformation, Neoplastic; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lisuride; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Pituitary Irradiation; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed	1993
Evaluation of three-dimensional MRI exploration of prolactin-secreting microadenomas. Journal of neuroradiology = Journal de neuroradiologie, 1993, Volume: 20, Issue:4 Topics: Adolescent; Adult; Arachnoid; Bromocriptine; Contrast Media; Diagnosis, Differential; Evaluation Studies as Topic; Female; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1993
Reversible dementia due to macroprolactinoma. Case report. Journal of neurosurgery, 1993, Volume: 79, Issue:1 Topics: Behavior; Bromocriptine; Dementia; Humans; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Pituitary Neoplasms; Prolactinoma	1993
Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment. Acta endocrinologica, 1993, Volume: 128, Issue:5 Topics: Adult; Bone Density; Bromocriptine; Calcitonin; Calcium; Estradiol; Female; Growth Hormone; Humans; Hyperprolactinemia; Insulin-Like Growth Factor I; Lumbar Vertebrae; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Radioimmunoassay; Time Factors	1993
Imaging of dopamine D2 and somatostatin receptors in vivo using single-photon emission tomography in a patient with a TSH/PRL-producing pituitary macroadenoma. European journal of nuclear medicine, 1993, Volume: 20, Issue:6 Topics: Administration, Oral; Bromocriptine; Humans; Injections, Subcutaneous; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2; Receptors, Somatostatin; Thyrotropin; Tomography, Emission-Computed, Single-Photon	1993
Nerve growth factor suppresses the transforming phenotype of human prolactinomas. Proceedings of the National Academy of Sciences of the United States of America, 1993, Sep-01, Volume: 90, Issue:17 Topics: Animals; Binding, Competitive; Bromocriptine; Cell Division; Cell Membrane; Humans; Kinetics; Mice; Mice, Nude; Neoplasm Transplantation; Nerve Growth Factors; Phenotype; Pituitary Neoplasms; Prolactin; Prolactinoma; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Receptor, trkA; Receptors, Dopamine D2; Receptors, Nerve Growth Factor; Sulpiride; Thymidine; Transplantation, Heterologous; Tumor Cells, Cultured	1993
[Prolactin-secreting macroadenoma in an adolescent girl: response to the medical treatment and follow-up method]. Pediatrie, 1993, Volume: 48, Issue:3 Topics: Adolescent; Bromocriptine; Female; Follicle Stimulating Hormone; Follow-Up Studies; Growth Hormone; Humans; Luteinizing Hormone; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactin; Prolactinoma	1993
Long term therapy of patients with macroprolactinoma using repeatable injectable bromocriptine. The Journal of clinical endocrinology and metabolism, 1993, Volume: 76, Issue:2 Topics: Adolescent; Adult; Aged; Bromocriptine; Estradiol; Female; Humans; Injections, Intramuscular; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1993
Spontaneous shrinking of a macroprolactinoma. Neurochirurgia, 1993, Volume: 36, Issue:1 Topics: Adult; Bromocriptine; Follow-Up Studies; Garlic; Humans; Male; Neoplasm Regression, Spontaneous; Pituitary Neoplasms; Plants, Medicinal; Prolactin; Prolactinoma; Tomography, X-Ray Computed	1993
[Statistical survey of prolactin producing tumor in Japan]. Nihon rinsho. Japanese journal of clinical medicine, 1993, Volume: 51 Suppl Topics: Adult; Age Factors; Bromocriptine; Female; Humans; Japan; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Function Tests; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma; Reference Standards; Sex Factors	1993
Topical effect of bromocriptine on rat-transplanted human prolactinomas. Acta neurochirurgica, 1993, Volume: 120, Issue:3-4 Topics: Animals; Bromocriptine; Cell Division; Humans; Immunoenzyme Techniques; Injections, Intralesional; Neoplasm Transplantation; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Tumor Cells, Cultured	1993
Effect of chronic bromocriptine treatment on psychological profile of patients with PRL-secreting pituitary adenomas. Psychoneuroendocrinology, 1993, Volume: 18, Issue:1 Topics: Adult; Aggression; Anxiety; Bromocriptine; Female; Hormones; Hostility; Humans; Middle Aged; MMPI; Pituitary Neoplasms; Prolactinoma; Psychological Tests	1993
Long-acting injectable bromocriptine (Parlodel LAR) in the chronic treatment of prolactin-secreting macroadenomas. Fertility and sterility, 1993, Volume: 59, Issue:5 Topics: Adenoma; Adolescent; Adult; Analysis of Variance; Bromocriptine; Delayed-Action Preparations; Female; Humans; Injections; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Visual Fields	1993
Aspects of medical therapy of neuroendocrine disorders. Pharmacy world & science : PWS, 1993, Apr-23, Volume: 15, Issue:2 Topics: Bromocriptine; Cushing Syndrome; Endocrine System Diseases; Humans; Nervous System Diseases; Neurosecretory Systems; Octreotide; Pituitary Neoplasms; Prolactinoma	1993
[Prolactin adenoma developed during puberty. Diagnosis and long-term course. 9 cases]. Presse medicale (Paris, France : 1983), 1993, Feb-27, Volume: 22, Issue:7 Topics: Adolescent; Bromocriptine; Child; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Pituitary Neoplasms; Prolactinoma; Puberty; Time Factors	1993
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas. British journal of cancer, 1995, Volume: 72, Issue:6 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cell Division; Dopamine; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Nerve Growth Factors; Pituitary Neoplasms; Prolactin; Prolactinoma; Sensitivity and Specificity	1995
Normal growth and pubertal development during bromocriptine therapy in two patients with prolactinoma. Endocrine journal, 1995, Volume: 42, Issue:4 Topics: Adolescent; Bromocriptine; Dopamine Agonists; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Puberty	1995
Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up. The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:5 Topics: Adolescent; Adult; Aged; Amenorrhea; Bromocriptine; Female; Follow-Up Studies; Growth Hormone; Humans; Middle Aged; Neoplasm Recurrence, Local; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Pregnancy Outcome; Prolactinoma; Reoperation	1996
Relative resistance of a macroprolactinoma to bromocriptine therapy during pregnancy. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1996, Volume: 10, Issue:2 Topics: Adult; Bromocriptine; Drug Resistance, Neoplasm; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Vision Disorders	1996
Hyperprolactinemia and reproductive disorders--a profile from north east. The Journal of the Association of Physicians of India, 1995, Volume: 43, Issue:9 Topics: Bromocriptine; Female; Humans; Hyperprolactinemia; Hypothyroidism; Incidence; India; Infertility, Female; Menstruation Disturbances; Pituitary Neoplasms; Pregnancy; Prolactinoma	1995
[Macroprolactinoma]. Deutsche medizinische Wochenschrift (1946), 1996, Jul-26, Volume: 121, Issue:30 Topics: Bromocriptine; Dopamine Agonists; Humans; Male; Middle Aged; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma	1996
Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism. Molecular endocrinology (Baltimore, Md.), 1996, Volume: 10, Issue:3 Topics: Animals; Antineoplastic Agents; Bromocriptine; Cell Division; Dopamine Agents; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Nerve Growth Factors; Oligonucleotides, Antisense; Pituitary Neoplasms; Prolactinoma; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Receptor, Nerve Growth Factor; Receptor, trkA; Receptors, Dopamine D2; Receptors, Nerve Growth Factor; Tumor Cells, Cultured	1996
15-year-old boy with ocular palsy and headache. Invasive macroprolactinoma. European journal of pediatrics, 1996, Volume: 155, Issue:8 Topics: Adolescent; Bromocriptine; Cortisone; Dopamine Agonists; Eye Diseases; Headache; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Radionuclide Imaging; Thyroxine; Treatment Outcome	1996
[Prolactin-secreting adenoma]. La Revue du praticien, 1996, Jun-15, Volume: 46, Issue:12 Topics: Bromocriptine; Diagnosis, Differential; Dopamine Agents; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma	1996
Bromocriptine as adjunctive therapy to clozapine in treatment-resistant schizophrenia. Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1996, Volume: 41, Issue:7 Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Pituitary Neoplasms; Prolactinoma; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology	1996
Alteration of G alpha subunits mRNA levels in bromocriptine resistant prolactinomas. Journal of neuroendocrinology, 1996, Volume: 8, Issue:10 Topics: Adenoma; Adult; Bromocriptine; Dopamine Agonists; Drug Resistance, Neoplasm; Female; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Macromolecular Substances; Male; Pituitary Neoplasms; Polymerase Chain Reaction; Prolactinoma; Receptors, Dopamine D2; Reproducibility of Results; RNA, Messenger; Transcription, Genetic	1996
Prolactinomas resistant to bromocriptine: long-term efficacy of quinagolide and outcome of pregnancy. European journal of endocrinology, 1996, Volume: 135, Issue:4 Topics: Aminoquinolines; Bromocriptine; Dopamine Agonists; Drug Resistance; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma	1996
Symptoms of pituitary apoplexy rapidly reversed with bromocriptine. Case report. Journal of neurosurgery, 1996, Volume: 85, Issue:6 Topics: Adult; Bromocriptine; Humans; Magnetic Resonance Imaging; Male; Oculomotor Nerve Diseases; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma	1996
Chiasmal herniation as a complication of bromocriptine therapy. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 1996, Volume: 16, Issue:4 Topics: Bromocriptine; Cranial Nerve Diseases; Dopamine Agonists; Encephalocele; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Optic Chiasm; Pituitary Neoplasms; Prolactinoma; Vision Disorders; Visual Fields	1996
Macroprolactinomas as cause of delayed puberty. A report of two cases and effects of medical therapy. Minerva endocrinologica, 1996, Volume: 21, Issue:2 Topics: Adolescent; Bromocriptine; Dopamine Agonists; Dwarfism, Pituitary; Hemianopsia; Humans; Male; Ophthalmoplegia; Pituitary Neoplasms; Prolactinoma; Puberty, Delayed	1996
Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:12 Topics: Acromegaly; Adenoma; Adolescent; Adult; Aged; Benzamides; Bromocriptine; Cerebellum; Corpus Striatum; Cushing Syndrome; Dopamine Agonists; Female; Humans; Lisuride; Male; Middle Aged; Nelson Syndrome; Pituitary Neoplasms; Prolactinoma; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon	1996
Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment. Methods and findings in experimental and clinical pharmacology, 1996, Volume: 18, Issue:9 Topics: Adult; Aldosterone; Bromocriptine; Case-Control Studies; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Female; Humans; Metoclopramide; Pituitary Neoplasms; Prolactin; Prolactinoma; Radioimmunoassay; Reference Values	1996
Large macroprolactinoma treated with bromocriptine alone. Annals of the Academy of Medicine, Singapore, 1996, Volume: 25, Issue:6 Topics: Administration, Oral; Adult; Bromocriptine; Dopamine Agonists; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed	1996
[Pregnancy in hyperprolactinemic patients]. Zentralblatt fur Gynakologie, 1996, Volume: 118, Issue:11 Topics: Adult; Breast Feeding; Bromocriptine; Combined Modality Therapy; Female; Humans; Hyperprolactinemia; Hypophysectomy; Infant, Newborn; Magnetic Resonance Imaging; Pituitary Gland; Pituitary Neoplasms; Postoperative Complications; Pregnancy; Pregnancy Complications; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactin; Prolactinoma; Retrospective Studies; Tomography, X-Ray Computed	1996
Management of prolactinomas. The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:4 Topics: Bromocriptine; Dopamine Agonists; Female; Humans; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactinoma	1997
Sex-related difference in the growth of prolactinomas: a clinical and proliferation marker study. The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:7 Topics: Adolescent; Adult; Age Factors; Aged; Biomarkers; Bromocriptine; Cell Division; Female; Humans; Ki-67 Antigen; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Proliferating Cell Nuclear Antigen; Retrospective Studies; Sex Factors	1997
Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors. The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:9 Topics: Adenoma; Adenoma, Islet Cell; Aminoquinolines; Bromocriptine; Dopamine Agonists; Endocrine Gland Neoplasms; Hormone Antagonists; Hormones; Humans; Insulinoma; Pancreatic Neoplasms; Pituitary Neoplasms; Prolactinoma; Receptors, Somatostatin; Somatostatin; Tumor Cells, Cultured	1997
Management of incidental pituitary microadenomas: a cost-effectiveness analysis. The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:11 Topics: Adenoma; Bromocriptine; Cost-Benefit Analysis; Dexamethasone; Humans; Insulin-Like Growth Factor I; Magnetic Resonance Imaging; Markov Chains; Models, Statistical; Pituitary Neoplasms; Prolactin; Prolactinoma	1997
[Bromocriptine monotherapy of a prolactinoma causing erectile dysfunction]. Archivos espanoles de urologia, 1997, Volume: 50, Issue:5 Topics: Adult; Bromocriptine; Dopamine Agonists; Erectile Dysfunction; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prolactinoma; Radiography	1997
Hyperprolactinaemia in males: a heterogeneous disorder. Australian and New Zealand journal of medicine, 1997, Volume: 27, Issue:4 Topics: Adult; Aged; Bromocriptine; Follow-Up Studies; Hormone Antagonists; Humans; Hyperprolactinemia; Hypogonadism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Tomography, X-Ray Computed	1997
Effects of bromocriptine and terguride on cell proliferation and apoptosis in the estrogen-stimulated anterior pituitary gland of the rat. Neurologia medico-chirurgica, 1997, Volume: 37, Issue:12 Topics: Animals; Apoptosis; Bromocriptine; Cell Division; Cell Migration Inhibition; Dopamine Agonists; Estradiol; Female; Hormone Antagonists; Lisuride; Neoplastic Cells, Circulating; Pituitary Gland; Pituitary Neoplasms; Prolactinoma; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar	1997
Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy. Clinical endocrinology, 1998, Volume: 48, Issue:1 Topics: Adult; Aged; Bromocriptine; Drug Synergism; Female; Growth Hormone; Hormone Antagonists; Humans; Male; Middle Aged; Oligopeptides; Pituitary Neoplasms; Prolactin; Prolactinoma; Sermorelin; Statistics, Nonparametric	1998
Late development of resistance to bromocriptine in a patient with macroprolactinoma. Hormone research, 1998, Volume: 49, Issue:5 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1998
[Disappearance of the radiographic image of a macroprolactinoma after treatment with bromocriptine]. Ginecologia y obstetricia de Mexico, 1998, Volume: 66 Topics: Adult; Amenorrhea; Bromocriptine; Female; Galactorrhea; Humans; Pituitary Neoplasms; Prolactinoma; Remission, Spontaneous; Tomography, X-Ray Computed	1998
Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. Clinical endocrinology, 1998, Volume: 48, Issue:5 Topics: Adult; Bromocriptine; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Regression Analysis; Retrospective Studies; Weight Gain	1998
Analyzing amenorrhea. Hospital practice (1995), 1998, Jul-15, Volume: 33, Issue:7 Topics: Adult; Amenorrhea; Bromocriptine; Contraceptives, Oral; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Hypothalamus; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy Tests; Prolactinoma; Uterus	1998
Pituitary apoplexy in an adolescent with prolactin-secreting adenoma. Hormone research, 1998, Volume: 50, Issue:1 Topics: Adolescent; Bromocriptine; Female; Humans; Hydrocortisone; Magnetic Resonance Imaging; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma	1998
Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up. The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:8 Topics: Adolescent; Amenorrhea; Aminoquinolines; Bromocriptine; Child; Dopamine Agonists; Drug Resistance; Female; Follow-Up Studies; Galactorrhea; Growth Disorders; Humans; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Puberty	1998
Surgery combined with dopamine agonists versus dopamine agonists alone in long-term treatment of macroprolactinoma: a retrospective study. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1998, Volume: 106, Issue:3 Topics: Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Dopamine Agonists; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Hypotension, Orthostatic; Male; Middle Aged; Nausea; Pituitary Gland; Pituitary Hormones; Pituitary Neoplasms; Prolactin; Prolactinoma; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Surgical Procedures, Operative; Treatment Outcome; Vision Disorders; Visual Fields	1998
Prolactin-secreting macroadenoma in a prepubertal girl. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 1998, Volume: 14, Issue:10 Topics: Bromocriptine; Child; Combined Modality Therapy; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Postoperative Care; Prolactin; Prolactinoma; Puberty; Tomography, X-Ray Computed	1998
Shock syndrome induced by bromocriptine test in a patient with prolactinoma--case report. Neurologia medico-chirurgica, 1998, Volume: 38, Issue:10 Topics: Aged; Bromocriptine; Humans; Male; Neoplasm Recurrence, Local; Pituitary Neoplasms; Prolactinoma; Shock; Syndrome; Vasodilator Agents	1998
Serum prolactin concentration in patients taking neuroleptic drugs. Clinical endocrinology, 1998, Volume: 49, Issue:4 Topics: Adolescent; Adult; Antipsychotic Agents; Bromocriptine; Diagnosis, Differential; Female; Fluoroimmunoassay; Humans; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography	1998
Surgical indication after bromocriptine therapy on giant prolactinomas: effects and limitations of the medical treatment. Endocrine journal, 1998, Volume: 45, Issue:4 Topics: Adult; Aged; Brain; Bromocriptine; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1998
The long-term effects of pregnancy and bromocriptine treatment on prolactinomas--the value of radiologic studies. Early pregnancy : biology and medicine : the official journal of the Society for the Investigation of Early Pregnancy, 1997, Volume: 3, Issue:4 Topics: Adult; Bromocriptine; Chorionic Gonadotropin; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Retrospective Studies; Tomography, X-Ray Computed	1997
Rapid enlargement and recurrence of a preexisting intrasellar craniopharyngioma during the course of two pregnancies. Case report. Journal of neurosurgery, 1999, Volume: 91, Issue:2 Topics: Adult; Bromocriptine; Craniopharyngioma; Diagnosis, Differential; Disease Progression; Female; Follow-Up Studies; Hormone Antagonists; Humans; Neoplasm Recurrence, Local; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma; Sphenoid Bone	1999
[Prolactinoma as a cause of primary amenorrhea in a 16-year-old girl]. Ginekologia polska, 1999, Volume: 70, Issue:5 Topics: Adolescent; Amenorrhea; Bromocriptine; Female; Gonadal Steroid Hormones; Hormone Antagonists; Humans; Menarche; Pituitary Neoplasms; Prolactinoma	1999
Gangliocytoma masquerading as a prolactinoma. Case report. Journal of neurosurgery, 1999, Volume: 91, Issue:3 Topics: Adult; Bromocriptine; Diagnosis, Differential; Follow-Up Studies; Ganglioneuroma; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Neoplasm, Residual; Neurofilament Proteins; Pituitary Neoplasms; Prolactin; Prolactinoma; Synaptophysin; Temporal Lobe	1999
Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas. The Journal of clinical endocrinology and metabolism, 1999, Volume: 84, Issue:9 Topics: Adenoma; Bromocriptine; Dopamine Agonists; Gastrinoma; Gastrins; Human Growth Hormone; Humans; Insulin; Insulin Secretion; Insulinoma; Interferon alpha-2; Interferon-alpha; Octreotide; Pancreatic Neoplasms; Pituitary Neoplasms; Prolactin; Prolactinoma; Recombinant Proteins; Somatostatin; Tumor Cells, Cultured	1999
High prolactin level. Journal of neurosurgery, 2000, Volume: 92, Issue:2 Topics: Adenoma; Bromocriptine; Diagnosis, Differential; Dopamine; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Predictive Value of Tests; Prolactin; Prolactinoma	2000
Peripubertal prolactinomas: clinical presentation and long-term outcome with different therapeutic approaches. Journal of pediatric endocrinology & metabolism : JPEM, 2000, Volume: 13, Issue:3 Topics: Adolescent; Bromocriptine; Child; Female; Humans; Male; Pituitary Neoplasms; Prolactinoma	2000
Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. Clinical endocrinology, 2000, Volume: 52, Issue:3 Topics: Adolescent; Adult; Aminoquinolines; Analysis of Variance; Biomarkers; Bone Density; Bone Remodeling; Bromocriptine; Cabergoline; Case-Control Studies; Collagen; Collagen Type I; Dopamine Agonists; Ergolines; Female; Femur Neck; Humans; Longitudinal Studies; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Osteoporosis; Peptides; Pituitary Neoplasms; Prolactinoma; Regression Analysis	2000
Prolactin-secreting pituitary adenoma in neuroleptic treated patients with psychotic disorder. European archives of psychiatry and clinical neuroscience, 2000, Volume: 250, Issue:1 Topics: Adult; Aminoquinolines; Antipsychotic Agents; Bipolar Disorder; Bromocriptine; Clozapine; Comorbidity; Dopamine Agonists; Dopamine Antagonists; Drug Interactions; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Psychoses, Substance-Induced; Psychotic Disorders	2000
Acute shrinkage of a macroprolactinoma masquerading as pituitary apoplexy. The Israel Medical Association journal : IMAJ, 2000, Volume: 2, Issue:3 Topics: Adult; Bromocriptine; Diagnostic Errors; Humans; Magnetic Resonance Imaging; Male; Pituitary Apoplexy; Pituitary Neoplasms; Prolactinoma	2000
Microprolactinoma: medical or surgical treatment as first line approach? The case for medical therapy. Journal of endocrinological investigation, 2000, Volume: 23, Issue:2 Topics: Bromocriptine; Dopamine Agonists; Humans; Pituitary Neoplasms; Prolactin; Prolactinoma	2000
Hormone secretion by cell culture of human GH-PRL secreting pituitary adenomas: effects of bromocriptine. Journal of Tongji Medical University = Tong ji yi ke da xue xue bao, 1998, Volume: 18, Issue:3 Topics: Adenoma; Bromocriptine; Dopamine Agonists; Female; Growth Hormone; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Tumor Cells, Cultured	1998
Involvement of p38 mitogen-activated protein kinase activation in bromocriptine-induced apoptosis in rat pituitary GH3 cells. Biology of reproduction, 2000, Volume: 62, Issue:6 Topics: Animals; Apoptosis; Bromocriptine; Dopamine D2 Receptor Antagonists; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pituitary Neoplasms; Prolactinoma; Rats; Receptors, Thyrotropin-Releasing Hormone; Signal Transduction; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured	2000
Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment. Clinical endocrinology, 2000, Volume: 52, Issue:6 Topics: Adult; Amenorrhea; Bromocriptine; Case-Control Studies; Female; Hormone Antagonists; Humans; Hyperprolactinemia; Luteinizing Hormone; Pituitary Neoplasms; Prolactin; Prolactinoma; Secretory Rate; Statistics, Nonparametric	2000
[Prolactinomas in Yaounde: analytical study of 36 consecutive cases followed in the internal medicine department of the Yaounde Hospital from 1990 to 1996]. Bulletin de la Societe de pathologie exotique (1990), 2000, Volume: 93, Issue:2 Topics: Bromocriptine; Cameroon; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Surgical Procedures, Operative; Testosterone; Tomography, X-Ray Computed	2000
[Prolactinoma in a child showing high MIB-1 labeling index: a case report]. No shinkei geka. Neurological surgery, 2000, Volume: 28, Issue:6 Topics: Bromocriptine; Child; Hormone Antagonists; Humans; Hypophysectomy; Ki-67 Antigen; Male; Mitotic Index; Pituitary Neoplasms; Postoperative Care; Prolactin; Prolactinoma; Radiotherapy, Adjuvant	2000
Cerebrospinal fluid (CSF) rhinorrhoea occurring six days after commencement of bromocriptine for invasive macroprolactinoma. Australian and New Zealand journal of medicine, 2000, Volume: 30, Issue:3 Topics: Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Dopamine Agonists; Humans; Male; Pituitary Neoplasms; Prolactinoma	2000
[Prolactinoma in man: clinical and histological characteristics]. Annales d'endocrinologie, 2000, Volume: 61, Issue:3 Topics: Adolescent; Adult; Bromocriptine; Cell Division; Drug Resistance; Female; Hormone Antagonists; Humans; Ki-67 Antigen; Male; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; Proliferating Cell Nuclear Antigen; Retrospective Studies; Sex Characteristics	2000
Optic chiasmal herniation--an under recognized complication of dopamine agonist therapy for macroprolactinoma. Clinical endocrinology, 2000, Volume: 53, Issue:4 Topics: Adult; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Hernia; Humans; Male; Middle Aged; Optic Chiasm; Pituitary Neoplasms; Prolactin; Prolactinoma; Vision Disorders; Visual Acuity	2000
[Role of hypothalamo-hypophyseal-adrenal axis in the pathogenesis of arterial hypertension in patients with prolactinoma of the anterior lobe of the hypophysis]. Terapevticheskii arkhiv, 2000, Volume: 72, Issue:9 Topics: Adult; Aldosterone; Bromocriptine; Data Interpretation, Statistical; Dopamine; Dopamine Agonists; Female; Humans; Hyperaldosteronism; Hyperprolactinemia; Hypertension; Hypothalamo-Hypophyseal System; Pituitary Neoplasms; Pituitary-Adrenal System; Prolactin; Prolactinoma; Radioimmunoassay; Renin	2000
Transsphenoidal surgery for pituitary gigantism and galactorrhea in a 3.5 year old child. Pituitary, 2000, Volume: 2, Issue:4 Topics: Bromocriptine; Child, Preschool; Dopamine Agonists; Female; Galactorrhea; Gigantism; Human Growth Hormone; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Postoperative Complications; Prolactin; Prolactinoma; Sphenoid Bone	2000
Efficacy of quinagolide in resistance to dopamine agonists: results of a multicenter study. Club de l'Hypophyse. Annales d'endocrinologie, 2000, Volume: 61, Issue:5 Topics: Aminoquinolines; Bromocriptine; Dopamine Agonists; Drug Resistance, Neoplasm; Female; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies	2000
[Decreased tumor size in hypophyseal macroadenoma--empty sella syndrome]. Praxis, 2001, Feb-15, Volume: 90, Issue:7 Topics: Bromocriptine; Empty Sella Syndrome; Female; Follow-Up Studies; Humans; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	2001
Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases. Journal of endocrinological investigation, 2001, Volume: 24, Issue:2 Topics: Acromegaly; Adenoma; Adolescent; Amenorrhea; Bromocriptine; Cabergoline; Child; Ergolines; Female; Headache; Human Growth Hormone; Humans; Male; Neoplasm Recurrence, Local; Octreotide; Pituitary Neoplasms; Prolactinoma; Puberty, Delayed; Radiotherapy; Treatment Outcome; Vision Disorders; Visual Fields	2001
Pregnancy in a patient with prolactinoma off treatment. The Journal of the Association of Physicians of India, 2000, Volume: 48, Issue:12 Topics: Adult; Bromocriptine; Diabetes, Gestational; Female; Hormone Antagonists; Humans; Infertility, Female; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications; Prolactinoma	2000
[Increased T1 signal of the residual normal anterior pituitary gland following medical treatment of pituitary prolactinoma]. Journal de radiologie, 2001, Volume: 82, Issue:4 Topics: Adult; Bromocriptine; Drug Monitoring; Female; Humans; Magnetic Resonance Imaging; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Treatment Outcome	2001
Rapid re-expansion of a macroprolactinoma after early discontinuation of bromocriptine. Pituitary, 2000, Volume: 3, Issue:3 Topics: Adult; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Time Factors	2000
Pituitary tumours in adolescence: clinical behaviour and neuroimaging features of seven cases. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2001, Volume: 8, Issue:3 Topics: Adolescent; Amenorrhea; Bromocriptine; Child; Craniotomy; Female; Galactorrhea; Growth Disorders; Growth Hormone; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Retrospective Studies	2001
[Reversible blindness caused by an invasive prolactinoma]. Deutsche medizinische Wochenschrift (1946), 2001, May-25, Volume: 126, Issue:21 Topics: Acute Disease; Adult; Blindness; Bromocriptine; Diagnosis, Differential; Dopamine Agonists; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma	2001
Pituitary prolactin-secreting macroadenoma combined with bilateral breast cancer in a 45-year-old male. Journal of endocrinological investigation, 2001, Volume: 24, Issue:6 Topics: Biopsy; Breast Neoplasms, Male; Bromocriptine; Carcinoma, Ductal, Breast; Estradiol; Hormone Antagonists; Humans; Hypogonadism; Male; Mammography; Mastectomy; Middle Aged; Neoplasms, Multiple Primary; Obesity; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Tomography, X-Ray Computed	2001
Clinical features and medical treatment of male prolactinomas. Acta neurochirurgica, 2001, Volume: 143, Issue:5 Topics: Adult; Bromocriptine; Decompression, Surgical; Dopamine Agonists; Hormone Antagonists; Humans; Libido; Lisuride; Male; Middle Aged; Optic Chiasm; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Treatment Outcome; Visual Fields	2001
Anti-tumoral action of octreotide and bromocriptine on the experimental rat prolactinoma: anti-proliferative and pro-apoptotic effects. Neuro endocrinology letters, 2001, Volume: 22, Issue:5 Topics: Animals; Antineoplastic Agents; Apoptosis; Bromocriptine; Cell Division; Diethylstilbestrol; DNA Fragmentation; Drug Implants; In Situ Nick-End Labeling; Male; Octreotide; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Rats, Inbred F344	2001
Latent prolactinoma on MRI-selective venous sampling and trans-sphenoidal microsurgical treatment. Neurological research, 2001, Volume: 23, Issue:7 Topics: Adult; Bromocriptine; Catheterization, Central Venous; Diabetes Insipidus, Neurogenic; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Menstruation Disturbances; Neurosurgical Procedures; Pituitary Gland, Anterior; Postoperative Complications; Predictive Value of Tests; Prolactin; Prolactinoma; Sphenoid Bone; Treatment Outcome	2001
Bromocriptine and the expression of c-myc and c-fos in human prolactinomas. Neurological research, 2001, Volume: 23, Issue:7 Topics: Adult; Antineoplastic Agents; Bromocriptine; Cell Division; DNA; DNA Replication; Dopamine Agonists; Female; Humans; Middle Aged; Prolactin; Prolactinoma; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-myc; Receptors, Estrogen; RNA, Messenger; Thymidine; Treatment Outcome; Tritium	2001
Gamma Knife radiosurgery as a primary surgical treatment for hypersecreting pituitary adenomas. Stereotactic and functional neurosurgery, 2000, Volume: 75, Issue:2-3 Topics: Adenoma; Adenoma, Acidophil; Adenoma, Basophil; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Bromocriptine; Female; Follow-Up Studies; Human Growth Hormone; Humans; Hyperglycemia; Hyperprolactinemia; Hypertension; Infertility, Female; Male; Middle Aged; Pituitary Hormones; Pituitary Neoplasms; Pregnancy; Pregnancy Outcome; Prolactin; Prolactinoma; Radiosurgery; Safety; Treatment Outcome	2000
Retention of dopamine 2 receptor mRNA and absence of the protein in craniospinal and extracranial metastasis of a malignant prolactinoma: a case report. European journal of endocrinology, 2002, Volume: 146, Issue:1 Topics: Brain Neoplasms; Bromocriptine; Dopamine Agonists; Humans; Immunohistochemistry; In Situ Hybridization; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Proteins; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Dopamine D2; RNA, Messenger; Spinal Neoplasms; Vision Disorders	2002
Three-dimensional imaging of hormone-secreting cells and their microvessel environment in estrogen-induced prolactinoma of the rat pituitary gland by confocal laser scanning microscopy. Applied immunohistochemistry & molecular morphology : AIMM, 2001, Volume: 9, Issue:4 Topics: Adrenocorticotropic Hormone; Animals; Bromocriptine; Estradiol; Estrogens; Female; Growth Hormone; Hormone Antagonists; Imaging, Three-Dimensional; Immunohistochemistry; Microcirculation; Microscopy, Confocal; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Rats, Wistar	2001
Gender-related differences in prolactin secretion in pituitary prolactinomas. Neuroradiology, 2002, Volume: 44, Issue:5 Topics: Adolescent; Adult; Age Factors; Bromocriptine; Female; Hormone Antagonists; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Sex Factors	2002
SUNCT syndrome in two patients with prolactinomas and bromocriptine-induced attacks. Neurology, 2002, Jun-11, Volume: 58, Issue:11 Topics: Adult; Bromocriptine; Female; Headache; Hormone Antagonists; Humans; Pituitary Neoplasms; Prolactinoma	2002
[Value of alpha subunit assay in pituitary pathology]. Annales d'endocrinologie, 1992, Volume: 53, Issue:4 Topics: Acromegaly; Adenoma; Adult; Aged; Bromocriptine; Female; Glycoprotein Hormones, alpha Subunit; Gonadotropins, Pituitary; Humans; Male; Middle Aged; Octreotide; Pituitary Neoplasms; Prolactinoma	1992
Prolactinomas and resistance to dopamine agonists. Hormone research, 1992, Volume: 38, Issue:1-2 Topics: Adolescent; Adult; Aminoquinolines; Bromocriptine; Child; Drug Resistance; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1992
Usefulness of CV 205-502 in a case of allergy to ergot-derived drugs. Hormone research, 1992, Volume: 38, Issue:3-4 Topics: Adult; Aminoquinolines; Bromocriptine; Drug Hypersensitivity; Female; Humans; Lisuride; Pituitary Neoplasms; Prolactin; Prolactinoma	1992
[Bromocriptine for macroprolactinomas. Discussion of 3 cases treated successfully]. Revista medica de Chile, 1992, Volume: 120, Issue:2 Topics: Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma	1992
Clinical management of prolactinomas: a ten-year experience. Medical oncology and tumor pharmacotherapy, 1992, Volume: 9, Issue:2 Topics: Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma	1992
Increased plasma VIP concentration in patients with prolactinoma. Endokrynologia Polska, 1992, Volume: 43, Issue:3 Topics: Adult; Analysis of Variance; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Vasoactive Intestinal Peptide	1992
Effects of the dopamine agonist CV 205-502 in human prolactinomas resistant to bromocriptine. The Journal of clinical endocrinology and metabolism, 1992, Volume: 74, Issue:3 Topics: Adult; Aminoquinolines; Antineoplastic Agents; Bromocriptine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Resistance; Female; Growth Hormone; Humans; Luteinizing Hormone; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed; Triiodothyronine; Tumor Cells, Cultured	1992
Effectiveness of computer-assisted perimetry in the follow-up of patients with pituitary microadenoma responsive to medical treatment. Clinical endocrinology, 1992, Volume: 37, Issue:2 Topics: Acromegaly; Adenoma; Adolescent; Adult; Bromocriptine; Diagnosis, Computer-Assisted; Evaluation Studies as Topic; Female; Humans; Male; Octreotide; Pituitary Neoplasms; Prolactinoma; Scotoma; Visual Field Tests	1992
A patient with a prolactinoma associated with an aldosterone producing adrenal adenoma: differences in dopaminergic regulation of PRL and aldosterone secretion. Endocrinologia japonica, 1992, Volume: 39, Issue:2 Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aldosterone; Bromocriptine; Dopamine; Female; Humans; Metoclopramide; Neoplasms, Multiple Primary; Nifedipine; Pituitary Neoplasms; Prolactin; Prolactinoma	1992
[A case of prolactinoma presenting with CSF rhinorrhea and CSF otorrhea during bromocriptine therapy]. No shinkei geka. Neurological surgery, 1992, Volume: 20, Issue:10 Topics: Bromocriptine; Cerebrospinal Fluid Otorrhea; Cerebrospinal Fluid Rhinorrhea; Drainage; Female; Humans; Hypophysectomy; Middle Aged; Pituitary Neoplasms; Prolactinoma	1992
Surgery, dopamine agonist therapy of combined treatment--results in prolactinoma patients after a 12 month follow-up. Zentralblatt fur Neurochirurgie, 1992, Volume: 53, Issue:3 Topics: Adolescent; Adult; Aged; Bromocriptine; Combined Modality Therapy; Dopamine; Female; Humans; Hyperprolactinemia; Hypophysectomy; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Hormones, Anterior; Pituitary Neoplasms; Postoperative Complications; Prolactin; Prolactinoma; Tomography, X-Ray Computed	1992
Cerebrospinal fluid rhinorrhea occurring in long-term bromocriptine treatment for macroprolactinomas. Surgical neurology, 1992, Volume: 38, Issue:4 Topics: Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactinoma	1992
[Prolactinoma as atypical tumor of the nasopharynx]. Anales otorrinolaringologicos ibero-americanos, 1992, Volume: 19, Issue:5 Topics: Administration, Oral; Adult; Bromocriptine; Humans; Male; Nasopharyngeal Neoplasms; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed	1992
[Evaluation of nuclear magnetic resonance imaging in tridimensional acquisition in the investigation of prolactin microadenoma]. Annales d'endocrinologie, 1992, Volume: 53, Issue:1 Topics: Adolescent; Adult; Bromocriptine; Female; Gadolinium; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Pituitary Neoplasms; Prolactinoma	1992
Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas. Agents and actions. Supplements, 1992, Volume: 38 ( Pt 2) Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Growth Hormone; Humans; Kallikreins; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Tissue Kallikreins	1992
Malignant prolactinoma. Acta endocrinologica, 1992, Volume: 127, Issue:5 Topics: Bromocriptine; Combined Modality Therapy; Female; Humans; Middle Aged; Orbital Neoplasms; Pergolide; Pituitary Neoplasms; Prolactin; Prolactinoma	1992
Hyperprolactinemia and lens opacities. Annals of ophthalmology, 1992, Volume: 24, Issue:11 Topics: Adult; Bromocriptine; Cataract; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Sex Factors	1992
Prolactin secreting pituitary carcinoma. Journal of neurology, neurosurgery, and psychiatry, 1992, Volume: 55, Issue:12 Topics: Adult; Brain; Bromocriptine; Combined Modality Therapy; Humans; Hypophysectomy; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Pituitary Irradiation; Pituitary Neoplasms; Prolactin; Prolactinoma	1992
[Regression of visual disorders under bromocriptine in patients with prolactin-secreting macroadenoma]. Presse medicale (Paris, France : 1983), 1992, Oct-24, Volume: 21, Issue:35 Topics: Adult; Bromocriptine; Eye Diseases; Female; Humans; Male; Pituitary Neoplasms; Prolactinoma	1992
Tissue kallikrein is associated with prolactin-secreting cells within human growth hormone-secreting adenomas. The Journal of endocrinology, 1992, Volume: 134, Issue:1 Topics: Adenoma; Adolescent; Adult; Aged; Bromocriptine; Female; Growth Hormone; Humans; Immunohistochemistry; Kallikreins; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1992
[Immediate efficacy of bromocriptine (BrC)-LAR in the treatment of macroprolactinomas: apropos of a case]. Revista clinica espanola, 1992, Volume: 191, Issue:2 Topics: Bromocriptine; Delayed-Action Preparations; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors	1992
[Experiences with bromocriptine treatment of female infertility due to hyperprolactinemia]. Zhonghua fu chan ke za zhi, 1992, Volume: 27, Issue:1 Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Prolactinoma; Retrospective Studies	1992
Macroprolactinomas with suprasellar extension: effect of bromocriptine withdrawal during one or more pregnancies. Fertility and sterility, 1992, Volume: 58, Issue:3 Topics: Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma; Retrospective Studies; Tomography, X-Ray Computed	1992
Treatment of extensively invasive (giant) prolactinomas with bromocriptine. The New Zealand medical journal, 1992, Apr-08, Volume: 105, Issue:931 Topics: Adult; Bromocriptine; Humans; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactinoma	1992
Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 cases. The Journal of clinical endocrinology and metabolism, 1992, Volume: 75, Issue:1 Topics: Adult; Aged; Bromocriptine; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Nausea; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma	1992
Combined bromocriptine and growth hormone (GH) treatment in GH-deficient children with macroprolactinoma in situ. The Journal of clinical endocrinology and metabolism, 1992, Volume: 75, Issue:1 Topics: Adolescent; Bromocriptine; Drug Therapy, Combination; Female; Growth Hormone; Humans; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Sella Turcica	1992
Effectiveness and long-term tolerability of the slow release oral form of bromocriptine on tumoral and non-tumoral hyperprolactinemia. Journal of endocrinological investigation, 1992, Volume: 15, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Bromocriptine; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Time Factors	1992
Cabergoline in the long-term therapy of hyperprolactinemic disorders. Acta endocrinologica, 1992, Volume: 126, Issue:6 Topics: Adolescent; Adult; Aged; Bromocriptine; Cabergoline; Drug Resistance; Ergolines; Female; Humans; Hyperprolactinemia; Male; Menstruation Disturbances; Middle Aged; Ovulation; Pituitary Neoplasms; Prolactinoma	1992
Effect of the new dopaminergic agonist CV 205-502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas. Clinical endocrinology, 1991, Volume: 34, Issue:1 Topics: Adult; Aged; Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Prospective Studies; Retrospective Studies	1991
CV 205-502 treatment of macroprolactinomas. Journal of endocrinological investigation, 1991, Volume: 14, Issue:9 Topics: Adult; Aminoquinolines; Bromocriptine; Dopamine Agents; Drug Resistance; Endocrine System Diseases; Female; Galactorrhea; Gonads; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1991
Pituitary prolactinoma associated with polycystic ovary--case report. Neurologia medico-chirurgica, 1991, Volume: 31, Issue:11 Topics: Adult; Amenorrhea; Bromocriptine; Female; Gonadotropin-Releasing Hormone; Humans; Hyperprolactinemia; Pituitary Neoplasms; Polycystic Ovary Syndrome; Prolactinoma; Vision Disorders	1991
Paradoxical prolactin response to growth hormone-releasing hormone in a patient with hyperprolactinemia and empty sella. Endocrinologia japonica, 1991, Volume: 38, Issue:2 Topics: Adult; Amenorrhea; Bromocriptine; Female; Growth Hormone-Releasing Hormone; Humans; Hyperprolactinemia; Male; Middle Aged; Pituitary Gland; Prolactin; Prolactinoma	1991
Decreased prolactin level in secretory granules and their increased exocytosis in estrogen-induced pituitary hyperplasia in rats treated with a dopamine agonist. Laboratory investigation; a journal of technical methods and pathology, 1991, Volume: 65, Issue:6 Topics: Animals; Bromocriptine; Cytoplasmic Granules; Estrogens; Exocytosis; Female; Microscopy, Electron; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Proteins; Rats; Rats, Inbred Strains	1991
[Retroperitoneal fibrosis in a patient treated with bromocriptine for a prolactinoma]. Journal d'urologie, 1991, Volume: 97, Issue:4-5 Topics: Bromocriptine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retroperitoneal Fibrosis; Tomography, X-Ray Computed; Urinary Catheterization	1991
[Use of bromocriptine during pregnancy and appearance of partial empty sella turcica in women with prolactinoma]. Revista clinica espanola, 1991, Volume: 189, Issue:7 Topics: Adult; Bromocriptine; Empty Sella Syndrome; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	1991
Zinc and bromocriptine long-term administration in patients with prolactinomas: effects on prolactin and thymulin circulating levels. The International journal of neuroscience, 1991, Volume: 59, Issue:1-3 Topics: Adult; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Radioimmunoassay; Thymic Factor, Circulating; Zinc	1991
Oral and injectable long-lasting bromocriptine preparations in hyperprolactinemia: comparison of their prolactin lowering activity, tolerability and safety. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1991, Volume: 5, Issue:4 Topics: Adult; Amenorrhea; Bromocriptine; Female; Humans; Hyperprolactinemia; Male; Middle Aged; Oligomenorrhea; Pituitary Neoplasms; Prolactin; Prolactinoma; Sexual Dysfunction, Physiological; Tomography, X-Ray Computed	1991
A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels. Hormone research, 1991, Volume: 35, Issue:3-4 Topics: Bromocriptine; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Thyrotropin-Releasing Hormone	1991
[The course of prolactinomas in adolescents]. Medicina, 1991, Volume: 51, Issue:2 Topics: Adolescent; Adult; Bromocriptine; Female; Follicle Stimulating Hormone; Follow-Up Studies; Humans; Luteinizing Hormone; Male; Pituitary Neoplasms; Prolactin; Prolactinoma; Thyrotropin	1991
Long-term effects of radiotherapy and bromocriptine treatment in patients with previous surgery for macroprolactinomas. Neurosurgery, 1991, Volume: 29, Issue:2 Topics: Adult; Aged; Bromocriptine; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pituitary Neoplasms; Postoperative Care; Prognosis; Prolactin; Prolactinoma; Radiotherapy; Radiotherapy Dosage; Retrospective Studies	1991
Experience with bromocriptine for the treatment of female infertility due to hyperprolactinemia. Chinese medical journal, 1991, Volume: 104, Issue:8 Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Prolactinoma; Retrospective Studies	1991
PET studies with L-[1-11C]tyrosine, L-[methyl-11C]methionine and 18F-fluorodeoxyglucose in prolactinomas in relation to bromocryptine treatment. European journal of nuclear medicine, 1991, Volume: 18, Issue:7 Topics: Adult; Bromocriptine; Carbon Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Methionine; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, Emission-Computed; Tyrosine	1991
Surgical outcome and pathological effects of bromocriptine preoperative treatment in prolactinomas. Pathology, research and practice, 1991, Volume: 187, Issue:5 Topics: Adult; Bromocriptine; Female; Humans; Intraoperative Period; Male; Microscopy, Electron; Postoperative Complications; Preoperative Care; Prolactin; Prolactinoma; Retrospective Studies	1991
[Prolactinoma is more frequent among men than among women. A dopamine agonist is effective in the treatment]. Lakartidningen, 1990, Dec-12, Volume: 87, Issue:50 Topics: Adult; Aged; Bromocriptine; Dopamine Agents; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Sex Factors; Sweden	1990
Withdrawal of bromocriptine after long-term therapy for macroprolactinomas; effect on plasma prolactin and tumour size. Clinical endocrinology, 1991, Volume: 34, Issue:3 Topics: Adult; Aged; Bromocriptine; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1991
[Comparison of the therapeutic results of bromocriptine treatment of prolactin microadenoma and macroadenoma]. Zhonghua nei ke za zhi, 1990, Volume: 29, Issue:11 Topics: Adult; Bromocriptine; Female; Humans; Infertility, Female; Pituitary Neoplasms; Prolactin; Prolactinoma	1990
Treatment of hyperprolactinemia in major depression. The American journal of psychiatry, 1990, Volume: 147, Issue:6 Topics: Adult; Bromocriptine; Depressive Disorder; Female; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prolactin; Prolactinoma	1990
[Prolactin adenomas in Dakar]. Dakar medical, 1990, Volume: 35, Issue:2 Topics: Adult; Amenorrhea; Bromocriptine; Combined Modality Therapy; Female; Galactorrhea; Humans; Hyperprolactinemia; Pituitary Neoplasms; Prevalence; Prolactinoma; Radiography; Retrospective Studies; Sella Turcica; Senegal; Vision Disorders	1990
[Alteration of prolactin secretion after transsphenoidal adenomectomy for prolactinomas]. No to shinkei = Brain and nerve, 1990, Volume: 42, Issue:8 Topics: Adolescent; Adult; Bromocriptine; Female; Follow-Up Studies; Humans; Hypophysectomy; Male; Pituitary Neoplasms; Postoperative Period; Prolactin; Prolactinoma	1990
Long-term radiographic follow-up of the sella turcica in hyperprolactinaemic women. The Australian & New Zealand journal of obstetrics & gynaecology, 1990, Volume: 30, Issue:3 Topics: Adult; Bromocriptine; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Middle Aged; Pituitary Neoplasms; Prolactinoma; Radiography; Sella Turcica; Time Factors	1990
Management of prolactin-secreting pituitary adenomas. The Western journal of medicine, 1990, Volume: 153, Issue:5 Topics: Bromocriptine; Combined Modality Therapy; Female; Humans; Neoplasm Staging; Pituitary Neoplasms; Prolactinoma	1990
Lymphocyte abnormalities in patients with macro- and micro-prolactinoma: different effects of bromocriptine treatment in the two groups. The International journal of neuroscience, 1990, Volume: 51, Issue:3-4 Topics: Antibodies, Monoclonal; Antigens, CD; Bromocriptine; HLA-DR Antigens; Humans; Lymphocyte Activation; Lymphocytes; Pituitary Neoplasms; Prolactin; Prolactinoma; Reference Values	1990
NK activity in patients with pathological hyperprolactinemia: effect of bromocriptine. The International journal of neuroscience, 1990, Volume: 51, Issue:3-4 Topics: Adult; Bromocriptine; Female; Humans; Killer Cells, Natural; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Reference Values	1990
[2 cases of macroprolactinoma in adolescence]. Klinicheskaia meditsina, 1990, Volume: 68, Issue:11 Topics: Adolescent; Age Factors; Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactinoma	1990
[What is new in hyperprolactinemia?]. Revue francaise de gynecologie et d'obstetrique, 1990, Volume: 85, Issue:12 Topics: Abortion, Spontaneous; Bromocriptine; Female; Humans; Hyperprolactinemia; Infertility, Female; Pituitary Neoplasms; Pregnancy; Prolactinoma	1990
Results of primary treatment with bromocriptine of prolactinomas with extrasellar extension. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1990, Volume: 17, Issue:1 Topics: Bromocriptine; Female; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma	1990
Parlodel LAR in the treatment of macroprolactinomas. Acta endocrinologica, 1990, Volume: 122, Issue:2 Topics: Adult; Bromocriptine; Delayed-Action Preparations; Drug Tolerance; Female; Humans; Male; Middle Aged; Pharmaceutical Vehicles; Pituitary Neoplasms; Prolactin; Prolactinoma; Visual Fields	1990
[Treatment of macroprolactinomas with delayed bromocriptine. Effectiveness of a single intramuscular injection]. Medicina clinica, 1990, Feb-03, Volume: 94, Issue:4 Topics: Adolescent; Adult; Aged; Bromocriptine; Delayed-Action Preparations; Drug Evaluation; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Vision Disorders	1990
Visual function improvement in patients with macroprolactinomas treated with bromocriptine. American journal of ophthalmology, 1990, May-15, Volume: 109, Issue:5 Topics: Adult; Aged; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed; Vision, Ocular; Visual Acuity; Visual Fields	1990
[Treatment of prolactin-secreting pituitary tumors with bromocriptine]. Harefuah, 1990, Feb-01, Volume: 118, Issue:3 Topics: Adult; Bromocriptine; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1990
The occurrence of macroscopical pituitary calcifications in prolactinomas. Neuroradiology, 1990, Volume: 31, Issue:6 Topics: Bromocriptine; Calculi; Female; Humans; Pituitary Diseases; Pituitary Neoplasms; Prolactin; Prolactinoma; Radiography; Sella Turcica	1990
Spontaneous prolactin transplantable tumor in the Wistar/Furth rat (SMtTW): a new animal model of human prolactinoma. Cancer research, 1990, Jul-01, Volume: 50, Issue:13 Topics: Animals; Bromocriptine; Disease Models, Animal; Female; Microscopy, Electron; Neoplasm Transplantation; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats	1990
CSF rhinorrhea after dopamine agonist treatment for invasive macroprolactinoma. Surgical neurology, 1990, Volume: 34, Issue:2 Topics: Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Humans; Pituitary Neoplasms; Prolactinoma	1990
Giant invasive prolactinoma: a case report and review of nine further cases. The Quarterly journal of medicine, 1990, Volume: 74, Issue:275 Topics: Adult; Aged; Bromocriptine; Dopamine; Female; Humans; Jugular Veins; Male; Middle Aged; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactin; Prolactinoma; RNA, Messenger; Tumor Cells, Cultured	1990
Retroperitoneal fibrosis in a patient with macroprolactinoma treated with bromocriptine. BMJ (Clinical research ed.), 1989, May-13, Volume: 298, Issue:6683 Topics: Bromocriptine; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retroperitoneal Fibrosis	1989
Perifusion studies of bromocriptine-treated and untreated macroprolactinomas: effects of dopamine, bromocriptine and TRH. Clinical endocrinology, 1989, Volume: 30, Issue:6 Topics: Bromocriptine; Cell Survival; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Perfusion; Pituitary Neoplasms; Prolactin; Prolactinoma; Thyrotropin-Releasing Hormone; Tumor Cells, Cultured	1989
[Prolactin and pregnancy]. Rinsho byori. The Japanese journal of clinical pathology, 1989, Volume: 37, Issue:8 Topics: Adult; Amniotic Fluid; Anencephaly; Bromocriptine; Female; Fetal Blood; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma	1989
[Treatment of hypophyseal prolactin-secreting macroadenomas]. Recenti progressi in medicina, 1989, Volume: 80, Issue:9 Topics: Adult; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Pituitary Neoplasms; Prolactinoma; Retrospective Studies	1989
Prolactinomas presenting as primary amenorrhoea and delayed or arrested puberty: response to medical therapy. Clinical endocrinology, 1989, Volume: 30, Issue:2 Topics: Adolescent; Adult; Amenorrhea; Bromocriptine; Combined Modality Therapy; Female; Humans; Male; Pituitary Neoplasms; Prolactinoma; Puberty, Delayed	1989
Anatomical and functional effects of estrogen-induced prolactinomas on the rat hypothalamus. Journal of experimental pathology, 1989,Fall, Volume: 4, Issue:4 Topics: Animals; Bromocriptine; Estrogens; Female; Hypothalamus; Pituitary Neoplasms; Prolactinoma; Rats; Rats, Inbred F344	1989
Development of an invasive macroprolactinoma: a possible consequence of prolonged oestrogen replacement. Case report. British journal of obstetrics and gynaecology, 1989, Volume: 96, Issue:12 Topics: Adult; Bromocriptine; Estrogen Replacement Therapy; Female; Humans; Neoplasm Invasiveness; Pituitary Neoplasms; Prolactinoma	1989
[Long-term bromocriptine treatment of giant prolactinoma: report of a case]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1989, Volume: 78, Issue:12 Topics: Adult; Bromocriptine; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma	1989
Rhinorrhea following dopamine agonist therapy of invasive macroprolactinoma. Acta neurochirurgica, 1989, Volume: 96, Issue:3-4 Topics: Adult; Aged; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma	1989
A simple rapid method for prolactin assay by reversed passive hemagglutination: evaluation of its clinical application. European journal of obstetrics, gynecology, and reproductive biology, 1989, Volume: 30, Issue:3 Topics: Amenorrhea; Antibodies, Monoclonal; Bromocriptine; Female; Hemagglutination Tests; Humans; Metoclopramide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma; Radioimmunoassay	1989
Prolactinoma in an adolescent girl: unusual response to bromocriptine therapy. American journal of diseases of children (1960), 1989, Volume: 143, Issue:5 Topics: Adolescent; Bromocriptine; Female; Humans; Menstruation; Obesity; Pituitary Neoplasms; Prolactin; Prolactinoma	1989
Abnormal dopamine sensitivity in some human prolactinomas. Hormone research, 1989, Volume: 31, Issue:1-2 Topics: Bromocriptine; Cells, Cultured; Dopamine; Female; Humans; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine	1989
Resistance to bromocriptine in prolactinomas. The Journal of clinical endocrinology and metabolism, 1989, Volume: 69, Issue:3 Topics: 17-Hydroxycorticosteroids; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adolescent; Adult; Bromocriptine; Cell Membrane; Dopamine; Drug Resistance; Female; Growth Hormone; Humans; Kinetics; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Dopamine; Spiperone; Thyrotropin; Thyroxine; Tumor Cells, Cultured	1989
Hyperprolactinemia and its management. Boletin de la Asociacion Medica de Puerto Rico, 1989, Volume: 81, Issue:6 Topics: Adult; Bromocriptine; Drug Evaluation; Female; Humans; Hyperprolactinemia; Male; Prolactinoma	1989
Cerebrospinal fluid rhinorrhea occurring in long-term bromocriptine treatment for macroprolactinomas. Surgical neurology, 1989, Volume: 32, Issue:5 Topics: Adult; Bromocriptine; Cerebrospinal Fluid Rhinorrhea; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Tomography, X-Ray Computed	1989
Pituitary adenomas: possible role of bromocriptine in intratumoral hemorrhage. Radiology, 1989, Volume: 170, Issue:1 Pt 1 Topics: Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Bromocriptine; Child; Female; Hemorrhage; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies	1989
Successful treatment of a prolactin-producing pituitary macroadenoma with intravaginal bromocriptine mesylate: a novel approach to intolerance of oral therapy. Obstetrics and gynecology, 1989, Volume: 73, Issue:3 Pt 2 Topics: Administration, Intravaginal; Adult; Bromocriptine; Female; Humans; Nausea; Pituitary Neoplasms; Prolactinoma; Vomiting	1989
Experience relating to pregnancy, lactation, and the after-weaning condition of hyperprolactinemic patients treated with bromocriptine. Fertility and sterility, 1989, Volume: 51, Issue:3 Topics: Adult; Bromocriptine; Female; Humans; Hyperprolactinemia; Lactation; Menstruation; Pituitary Neoplasms; Postpartum Period; Pregnancy; Prolactin; Prolactinoma; Weaning	1989
Growth of prolactinoma despite lowering of serum prolactin by bromocriptine. Neurosurgery, 1989, Volume: 24, Issue:3 Topics: Adult; Bromocriptine; Female; Humans; Magnetic Resonance Imaging; Male; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Tomography, X-Ray Computed; Visual Acuity; Visual Fields	1989
Magnetic resonance imaging of tumours of the sellar region. Evaluation of treatment with bromocriptine retard. Acta radiologica. Supplementum, 1986, Volume: 369 Topics: Adenoma; Adult; Aged; Bromocriptine; Female; Growth Hormone; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Sella Turcica	1986
[Clinical treatment of prolactinoma in women: analysis of 40 cases]. Revista chilena de obstetricia y ginecologia, 1988, Volume: 53, Issue:3 Topics: Adenoma; Adolescent; Adult; Bromocriptine; Female; Humans; Menstruation Disturbances; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactin; Prolactinoma	1988
[Macroprolactinoma reduction and pregnancy induction with bromocriptine]. Ginecologia y obstetricia de Mexico, 1988, Volume: 56 Topics: Adult; Amenorrhea; Bromocriptine; Drug Evaluation; Female; Galactorrhea; Humans; Pituitary Neoplasms; Pregnancy; Prolactinoma; Remission Induction	1988
A case of large prolactinoma supposed to be cured by bromocriptine therapy. Endocrinologia japonica, 1988, Volume: 35, Issue:3 Topics: Adult; Bromocriptine; Humans; Male; Pituitary Neoplasms; Prolactin; Prolactinoma	1988
Effect of bromocriptine on secretion and morphology of human prolactin cell adenomas in vitro. Hormone research, 1988, Volume: 30, Issue:1 Topics: Adult; Aged; Bromocriptine; Cells, Cultured; Female; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma	1988
Treatment of prolactinomas and growth hormone-producing adenomas with an injectable bromocriptine retard preparation and a somatostatin analogue delivered by an implantable pump. Pathology, research and practice, 1988, Volume: 183, Issue:5 Topics: Acromegaly; Adenoma; Antineoplastic Agents; Bromocriptine; Delayed-Action Preparations; Female; Growth Hormone; Hormones; Humans; Magnetic Resonance Imaging; Male; Octreotide; Pituitary Neoplasms; Prolactin; Prolactinoma	1988
Changes in prolactinomas and somatotropinomas in humans treated with bromocriptine. Pathology, research and practice, 1988, Volume: 183, Issue:5 Topics: Bromocriptine; Cytoplasmic Granules; Exocytosis; Growth Hormone; Humans; Microscopy, Electron; Necrosis; Pituitary Neoplasms; Prolactinoma	1988
Ultrastructural study of prolactinoma after bromocriptine therapy. Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences, 1988, Volume: 4, Issue:12 Topics: Adolescent; Adult; Bromocriptine; Cytoplasmic Granules; Female; Humans; Male; Microscopy, Electron; Middle Aged; Pituitary Neoplasms; Prolactinoma	1988
[Prolactin adenomas in women under 20 years of age: apropos of 11 cases]. Medicina, 1988, Volume: 48, Issue:5 Topics: Adolescent; Adult; Bromocriptine; Female; Humans; Pituitary Neoplasms; Prolactinoma; Retrospective Studies	1988